JP2002525169A - Heart valve with tissue and outer sheath secured by anchor - Google Patents
Heart valve with tissue and outer sheath secured by anchorInfo
- Publication number
- JP2002525169A JP2002525169A JP2000571856A JP2000571856A JP2002525169A JP 2002525169 A JP2002525169 A JP 2002525169A JP 2000571856 A JP2000571856 A JP 2000571856A JP 2000571856 A JP2000571856 A JP 2000571856A JP 2002525169 A JP2002525169 A JP 2002525169A
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- piece
- frame
- heart valve
- sheath
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2415—Manufacturing methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
(57)【要約】 自家組織により準備された心臓弁を構成するための装置及び方法。3枚の組織片は、環状基部と、基部から延びる複数の交連ポストとを有する組織装着フレームにおいて、組織アンカーにより所定位置に保持されている。エラストマーシースは、組織片が固定フックから外れないように片上に緩く載っており、また弁葉を形成するように片を取り囲んでいる。片は、交連ポストに対して約65°の角度を有する接合線において相互に接触している。心臓弁は、短時間で、典型的には10分間で、外科手術により構成することができる。狭い接合角により、及び片が2つの柔軟性のない部材の間において締め付けられずに、所定位置に保持されるということにより、組織にかかる力が最低限となる。 (57) Abstract: An apparatus and method for constructing a heart valve prepared by autologous tissue. The three pieces of tissue are held in place by tissue anchors in a tissue mounting frame having an annular base and a plurality of commissure posts extending from the base. The elastomeric sheath rests loosely on the piece so that the piece does not come off the fixation hook and surrounds the piece to form a leaflet. The pieces are in contact with each other at a joint line having an angle of about 65 ° to the commissure posts. Heart valves can be surgically constructed in a short time, typically 10 minutes. Narrow joint angles and the fact that the pieces are held in place without being clamped between the two inflexible members minimize the force on the tissue.
Description
(発明の属する技術分野) 本発明は、アンカー及び外部シースにより所定の場所に保持された自家組織を
用いた心臓弁における改良に関するものである。心臓弁は、短時間で、典型的に
は10分間以内で、外科手術により構成することができる。TECHNICAL FIELD The present invention relates to an improvement in a heart valve using autologous tissue held in place by an anchor and an outer sheath. Heart valves can be surgically constructed in a short time, typically within 10 minutes.
【0001】 (発明の背景) 病気または機能不全である人間の心臓弁の代わりに使用するための種々のタイ
プの心臓弁が現在利用可能である。BACKGROUND OF THE INVENTION [0002] Various types of heart valves are currently available for use in place of diseased or dysfunctional human heart valves.
【0002】 一つの形態の心臓弁は、動物組織から構成され、典型的にはウシまたはブタの
動脈弁組織から構成される。これらの弁は、必要時より前に時間的余裕を十分と
って、研究所において構成され、アルデヒド溶液において保存されなければなら
ないのが、典型的である。当該技術専門の技術者が、これらの弁を組み立てる必
要がある。動物組織から構成された弁は比較的寿命が短い。寿命が短いことには
2つの要因がある。第1に、身体が、動物組織に対して該組織の石灰化の原因と
なる抗原反応を起こすので、時間とともに組織の柔軟性がなくなり感受性が高く
なって、機能不全に陥ること。第2に、組織は、抗原反応を低減させるために、
移植前にグルタルアルデヒドに保存されることが多く、このアルデヒドにより、
組織がタン皮状になり耐久性を有した状態となるが、開閉が繰り返しされること
によるひずみにより摩滅すること。One type of heart valve is composed of animal tissue, typically of bovine or porcine arterial valve tissue. These valves must typically be constructed in a laboratory and stored in an aldehyde solution with sufficient time allowance before needed. A technician of this skill needs to assemble these valves. Valves composed of animal tissue have a relatively short life. Short life is due to two factors. First, the body undergoes an antigenic reaction against animal tissue that causes calcification of the tissue, resulting in the tissue becoming less flexible and more sensitive over time, resulting in dysfunction. Second, the tissue is used to reduce the antigen response
It is often stored in glutaraldehyde before transplantation,
The tissue becomes skin-like and durable, but wears out due to strain caused by repeated opening and closing.
【0003】 従って、このような動物組織弁は広く利用されてはいるが、約5〜10年後に
交換しなければならない。弁の交換には、2度目の心臓を開く手術が必要となる
ことから、手術中に問題が生じる可能性がつきまとい、患者にとって危険な状況
が引き起こされる。[0003] Thus, while such animal tissue flaps are widely used, they must be replaced after about 5 to 10 years. Valve replacement requires a second heart-opening procedure, which entails potential problems during the procedure, creating a dangerous situation for the patient.
【0004】 機械心臓弁も利用可能である。この弁は、金属またはセラミックなどの堅い非
生物材料から形成されている。機械心臓弁は耐久性はあるが、弁の堅い非生物材
料面には血塊が生じやすい。血塊は、心臓発作または心臓麻痺を引き起こす可能
性があり、その結果、機械心臓弁を有する患者は、抗凝血薬を服用しなければな
らない。このような薬は出血を伴う合併症を引き起こしかねない。さらに、この
ような薬を服用する患者は、長期に渡り頻繁に、血液凝固時間についての検査を
受けなければならない。[0004] Mechanical heart valves are also available. The valve is formed from a rigid non-living material such as metal or ceramic. Although mechanical heart valves are durable, blood clots tend to form on the rigid non-living material side of the valve. Blood clots can cause a heart attack or heart attack, so that patients with mechanical heart valves must take anticoagulants. Such drugs can cause complications with bleeding. In addition, patients taking such drugs must undergo frequent and prolonged tests for blood clotting times.
【0005】 他のタイプの心臓弁、生体組織弁が、患者自身の組織により構成される。米国
特許第5,161,955号及び米国特許第5,326,371号などの、自家
組織心臓弁についての及び自家組織心臓弁の形成方法についての多くの特許が、
本出願の被譲渡人であるAutogenics社に対して発行されてきた。[0005] Other types of heart valves, biological tissue valves, are comprised of the patient's own tissue. Many patents on autologous heart valves and methods of forming autologous heart valves, such as U.S. Patent Nos. 5,161,955 and 5,326,371,
It has been issued to Autogenics, the assignee of the present application.
【0006】 (発明の概要) 本発明は、自家組織心臓弁を形成するための改良された装置及び方法を提供す
る。本発明の重要な要素は、自家組織と弁をフレームへ装着するための手段とを
形成することにより、組織に有害な力がかからないようにできることである。SUMMARY OF THE INVENTION The present invention provides improved devices and methods for forming autologous heart valves. An important element of the present invention is that by forming the autologous tissue and the means for attaching the valve to the frame, no harmful forces can be applied to the tissue.
【0007】 患者から摘出された心膜組織を、組織弁葉線に沿って配置された複数の組織固
定孔を有し、概ね半円形である3枚の別個の組織片へ形成することにより、自家
組織を正確に配置することができる。これらの組織固定孔の位置は、組織装着フ
レームに恒久的に取り付けられた組織固定フックに対応している。[0007] By forming pericardial tissue excised from the patient into three separate semi-circular pieces of tissue having a plurality of tissue fixation holes arranged along the tissue leaflet line, Self-organization can be accurately arranged. The locations of these tissue fixation holes correspond to tissue fixation hooks permanently attached to the tissue mounting frame.
【0008】 これら3枚の組織片は、組織装着フレームの周囲を完全に取り囲むように、組
織装着フレームの組織固定フックに連続して配置される。エラストマーシースは
、組織装着フレームの外側において引き伸ばされる。このシースは、組織が組織
固定フックから外れるのを防ぐもので、組織が自然閉鎖弁を形成するように、弁
葉線辺りの組織に緩く載っている。[0008] The three pieces of tissue are arranged continuously on the tissue fixing hook of the tissue mounting frame so as to completely surround the periphery of the tissue mounting frame. The elastomeric sheath is stretched outside the tissue mounting frame. The sheath prevents the tissue from coming off the tissue fixation hook and rests loosely on the tissue around the leaflet line so that the tissue forms a natural closure valve.
【0009】 本発明の重要な特徴は、組織にかかる力の低減が妨げられないように自家組織
が支持されることである。例えば、組織は、柔軟性のない2つの部材間で締め付
けられずに、組織固定孔に合わせられるアンカーと、エラストマーシース部材と
内側の組織装着フレームとの間において組織片の外周部と係合するエラストマー
シースとを組み合わせることにより、支持及び保持される。An important feature of the present invention is that the autologous tissue is supported such that a reduction in the force on the tissue is not impeded. For example, the tissue engages the outer perimeter of the tissue piece between the elastomeric sheath member and the inner tissue mounting frame, without being clamped between the two inflexible members, between the anchor that is aligned with the tissue anchoring hole. Supported and retained by combining with an elastomeric sheath.
【0010】 本発明の他の特徴は、組織片が、余分な組織領域を十分に備えるように形成さ
れていることであり、この結果、生理学的に相似する接合角度が提供されるので
、シースにより所定位置に保持された組織における伸張が低減され、これに伴い
、組織にかかる力がさらに低減される。[0010] Another feature of the present invention is that the piece of tissue is shaped to provide sufficient extra tissue area, thereby providing a physiologically similar joint angle, thus providing a sheath. Thus, the extension of the tissue held at the predetermined position is reduced, and accordingly, the force applied to the tissue is further reduced.
【0011】 (好ましい実施形態) 図1は、本発明により組み立てられた自家組織から成る心臓弁9を図示してい
る。この弁は、外科手術中に、患者自身の組織を用いて、いくつかの工場製造構
成部品から組み立てられる。図3C及び図7Aを参照すると、これらの構成部品
には、複数の組織固定フック34及び36を有する組織装着フレーム40(図3
C)が含まれる。この組織装着フレーム40は、3枚の別個の自家組織片50(
うち1つを図7Aに図示)を装着する。この3枚の片の最終組立構成体90を図
1に図示した。エラストマー外部シース42は、組織装着フレームを覆って、組
織片に過度の力をかけずに、組織をフレームの所定位置に保持するのを助ける。
環状縫合リング70は、組織装着フレーム及びエラストマーシースの基部に装着
されており、従来の方法により使用されて、組み立てられた弁9を患者の心臓内
の所定位置に保持する。以下に説明するように、この弁は、心臓を開く処置をす
る間に、外科医が外科手術により組み立てられるように設計されている。典型的
な組立時間は、10分程度である。組織装着フレーム40 組織装着フレーム40の構成部品を、図2A、図2B、図3A、図3B、図3
C、図3D、図4及び図5に図示する。図2Aに図示したのは、内フレーム10
であり、内フレーム10は基部12から延びる3本の交連ポスト14を有する基
部を伴い製造されるのが好ましい。図1に図示した組み立てられた弁において、
これらの交連ポスト14は弁の中の血流方向の軸線に沿って配置されている。3
本の交連ポスト14は、内フレームが組み立てられると、3本の交連ポストが1
20°の角度で分かれるように、内フレームに沿って等間隔を置いて配置される
のが好ましい。このポストは、スカラップ状壁16と連続しているのが好ましく
、また内フレームの端部18は、基部12と垂直というよりある角度で傾斜して
いるのが好ましい。複数の内フレーム孔20が、スカラップ状壁16及び交連ポ
スト14の周長に沿って配置されている。Preferred Embodiment FIG. 1 illustrates a heart valve 9 composed of autologous tissue assembled according to the present invention. The valve is assembled from several factory-manufactured components during the surgical procedure, using the patient's own tissue. Referring to FIGS. 3C and 7A, these components include a tissue mounting frame 40 (FIG. 3) having a plurality of tissue fixation hooks 34 and 36.
C) is included. The tissue mounting frame 40 includes three separate autologous tissue pieces 50 (
One of them is shown in FIG. 7A). The three piece final assembly 90 is shown in FIG. The elastomeric outer sheath 42 covers the tissue mounting frame and helps to hold the tissue in place on the frame without undue force on the tissue pieces.
An annular suture ring 70 is mounted to the base of the tissue mounting frame and elastomeric sheath and is used in a conventional manner to hold the assembled valve 9 in place within the patient's heart. As described below, the valve is designed to be surgically assembled by the surgeon during the procedure to open the heart. Typical assembly times are on the order of 10 minutes. The components of the tissue mounting frame 40 tissue mounting frame 40, 2A, 2B, 3A, 3B, 3
C, FIG. 3D, FIG. 4 and FIG. FIG. 2A illustrates the inner frame 10.
The inner frame 10 is preferably manufactured with a base having three commissure posts 14 extending from the base 12. In the assembled valve illustrated in FIG.
These commissure posts 14 are located along the blood flow axis in the valve. 3
When the inner frame is assembled, the three commissure posts 14
Preferably, they are equally spaced along the inner frame so as to split at an angle of 20 °. The post is preferably continuous with the scalloped wall 16 and the end 18 of the inner frame is preferably inclined at an angle rather than perpendicular to the base 12. A plurality of inner frame holes 20 are arranged along the circumference of the scalloped wall 16 and the commissure posts 14.
【0012】 内フレーム10は、ある種の金属及びプラスチックなど、生体内での使用に適
する種々の材料から形成することができる。形成材料としては、プラスチックよ
り金属が好ましいのが一般的であり、内フレーム10を形成するためにはエルジ
ロイが特に好ましい。特に好ましいプラスチックはデルリンである。The inner frame 10 can be formed from a variety of materials suitable for use in vivo, such as certain metals and plastics. As a forming material, metal is generally preferable to plastic, and Elgiloy is particularly preferable for forming the inner frame 10. A particularly preferred plastic is delrin.
【0013】 図2Bは、組織装着フレーム40の外フレーム部24を図示している。外フレ
ームは、内フレームと同様に、スカラップ状壁16aにより連続した複数の交連
ポスト14aを有する基部12aを伴い構成される。さらに外フレームの端部1
8aは傾斜しているのが好ましい。複数の外フレーム孔26が、図2Bにおいて
点線で示した弁葉線30に沿い配置されている。この弁葉線30は、スカラップ
状壁16a及び交連ポスト14aの周長に近接して配置されている。内フレーム
孔及び外フレーム孔の数は、弁の大きさにより異なるが、21個から24個であ
るのが一般的である。以下に説明するように、外フレーム孔は、内フレーム及び
外フレームが組み立てられると、対応の内フレーム孔と並置されるように形成さ
れている。さらに、外フレームは、ある種の金属及びプレスチックなどの種々の
材料から形成することができる。エルジロイが特に好ましい。FIG. 2B illustrates the outer frame 24 of the tissue mounting frame 40. The outer frame, like the inner frame, is configured with a base 12a having a plurality of commissure posts 14a continuous by scalloped walls 16a. Furthermore, the end 1 of the outer frame
8a is preferably inclined. A plurality of outer frame holes 26 are arranged along a leaf leaf line 30 indicated by a dotted line in FIG. 2B. The leaflet line 30 is disposed close to the circumference of the scalloped wall 16a and the commissure post 14a. The number of inner frame holes and outer frame holes varies depending on the size of the valve, but is generally 21 to 24. As described below, the outer frame holes are formed so as to be juxtaposed with the corresponding inner frame holes when the inner frame and the outer frame are assembled. In addition, the outer frame can be formed from various materials such as certain metals and prestics. Elgiloy is particularly preferred.
【0014】 溶接領域32のおよその位置を図2Bにハッチングにより示す。この溶接領域
は、2つの内フレーム10及び外フレーム24を恒久的に接着するように、後に
内フレーム10の外面に溶接される外フレーム24の内面の領域とされるのが一
般的である。The approximate location of the weld area 32 is shown by hatching in FIG. 2B. This welding area is generally an area on the inner surface of the outer frame 24 that is later welded to the outer surface of the inner frame 10 so that the two inner frames 10 and the outer frame 24 are permanently bonded.
【0015】 内フレーム10及び外フレーム24は、外形が円筒形となるように丸められる
。外フレーム24が単独で図3Aに図示されているが、この2つの円筒部材の外
形は、非常に似ている。次に、2つの部材10及び24は、互いに同心に配置さ
れ、図3Bに示した構造を形成するように、基部12に近接する溶接領域32に
おいてスポット溶接されている。フレーム端部18及び18aは、2つのフレー
ムが溶接されると120°の間隔を置いて配置される。The inner frame 10 and the outer frame 24 are rounded so that their outer shapes are cylindrical. Although the outer frame 24 is shown alone in FIG. 3A, the outer shapes of the two cylindrical members are very similar. Next, the two members 10 and 24 are positioned concentrically with each other and spot welded in a weld region 32 proximate the base 12 to form the structure shown in FIG. 3B. Frame ends 18 and 18a are spaced 120 ° apart when the two frames are welded.
【0016】 交連ポストのアンカー34(図4)及び弁葉線のアンカー36(図5)は、金
属、好ましくはエルジロイから製造される。このアンカー34はフック部34a
を含み、またアンカー36は突起部36aを含み、フック部34a及び突起部3
6aは、アンカーを組織装着フレーム40に恒久的に取り付けるために用いられ
ている。円筒であり、内フレーム孔20及び外フレーム孔26を介して連結され
た内フレーム及び外フレームの内側から、フック部が挿入されて、(図3C及び
図3Bに図示したように)フック部が外フレーム面の外側に延びている。突起部
36は、内フレーム10に配置され、より大きい対応の内フレーム孔20を通っ
て、外フレーム24の内面にスポット溶接される。図6にもっともよく図示され
ているように、突起部34aは、外フレーム24の内面に隣接しており、より大
きい対応の内フレーム孔20内に位置する。以下に明らかとなるだろうが、図4
及び図5に図示したように、交連ポストのアンカー34は、弁葉線アンカー用に
1層というより2層の組織を保持するために、弁葉線アンカー36より若干長い
。The commissure post anchors 34 (FIG. 4) and the leaflet anchors 36 (FIG. 5) are manufactured from metal, preferably Elgiloy. This anchor 34 is a hook portion 34a
And the anchor 36 includes a protrusion 36a, the hook 34a and the protrusion 3a.
6a is used to permanently attach the anchor to the tissue mounting frame 40. Hooks are inserted from the inside of the inner and outer frames, which are cylindrical and connected via the inner and outer frame holes 20 and 26, to engage the hooks (as shown in FIGS. 3C and 3B). It extends outside the outer frame surface. The protrusion 36 is located on the inner frame 10 and is spot welded to the inner surface of the outer frame 24 through the corresponding inner frame hole 20. As best shown in FIG. 6, the protrusion 34a is adjacent to the inner surface of the outer frame 24 and is located within a larger corresponding inner frame hole 20. As will become apparent below, FIG.
And as shown in FIG. 5, the anchor 34 of the commissure post is slightly longer than the leaflet anchor 36 to hold two layers of tissue rather than one layer for the leaflet anchor.
【0017】 図3Dは、外フレーム24において外フレーム孔26を延びる交連ポストアン
カー34のさらに詳細な図である。交連ポストアンカー34の突起部は、内フレ
ーム10のより大きい内フレーム孔20(図示せず)を通り、外フレーム24の
内壁にスポット溶接されている。FIG. 3D is a more detailed view of the commissure post anchor 34 that extends through the outer frame hole 26 in the outer frame 24. The projection of the commissure post anchor 34 passes through a larger inner frame hole 20 (not shown) in the inner frame 10 and is spot welded to the inner wall of the outer frame 24.
【0018】 図3C、図3D及び図6に図示したように交連ポストアンカー34のフック部
は上を向いているが、図3Cにおいて、弁葉線アンカー36のフック部は弁葉線
30から離れて下に向いていることが図示されている。各交連ポスト14には2
本の交連ポストアンカー34があるのが一般的だが、必ずしもそうでなくてもよ
い。As shown in FIGS. 3C, 3D, and 6, the hook portion of the commissure post anchor 34 faces upward, but in FIG. 3C, the hook portion of the leaflet line anchor 36 separates from the leaflet line 30. Is shown facing down. 2 for each commissure post 14
Typically, but not necessarily, a book commissure post anchor 34 is provided.
【0019】 組織装着フレーム40は、心臓を開く外科手術中に外科医が患者の弁を取り出
した後、その患者各人の必要に合うように種々の大きさに製造されている。現在
使用されている典型的な大きさは、19、21、23、及び25mmの弁である
。弁葉線アンカーの数は、組織装着フレームの大きさにより種々異なる。(1つ
のポストにつき2本で)6本の交連ポストのアンカー、及び1つの弁につき15
〜18本の弁葉線アンカーというのが一般的である。The tissue mounting frame 40 is manufactured in various sizes to suit the needs of each individual patient after the surgeon removes the patient's valves during the open heart surgery. Typical sizes currently used are 19, 21, 23, and 25 mm valves. The number of leaflet anchors varies depending on the size of the tissue mounting frame. 6 commissure post anchors (2 per post) and 15 per valve
It is common to have ~ 18 leaflet anchors.
【0020】 図6は、内フレーム10、外フレーム24、及び交連ポストアンカー34を示
す、組み立てられた組織装着フレーム40の片側から見た断面図である。2つの
交連ポストアンカー34は、内フレーム孔20を通り、外フレーム24の内壁に
溶接されている。図示してはいないが、弁葉線アンカー34も同様にフレーム4
0の下部に溶接されている。FIG. 6 is a cross-sectional view from one side of the assembled tissue mounting frame 40 showing the inner frame 10, outer frame 24, and commissure post anchors 34. The two commissure post anchors 34 pass through the inner frame hole 20 and are welded to the inner wall of the outer frame 24. Although not shown, the leaflet line anchor 34 is similarly connected to the frame 4.
0 is welded to the lower part.
【0021】 内フレーム10、外フレーム24、交連ポストアンカー34、及び弁葉アンカ
ー36が溶接されて組み立てられた後、組み立てられた組織装着フレーム40は
、その両面をダクロン布38により覆われる(図11Bを参照)。ダクロンは、
ポリエチレンテレフタレートに対するデュポン社の登録商標名である。After the inner frame 10, the outer frame 24, the commissure post anchors 34, and the leaflet anchors 36 are welded and assembled, the assembled tissue mounting frame 40 is covered on both sides with Dacron cloth 38 (FIG. 11B). Dacron
It is a registered trademark of DuPont for polyethylene terephthalate.
【0022】 図面においてこの布を図示することは難しいので、断面図である、図10C、
図11B、図11Cは、シース42及び縫合リング70(後述)と同様に、ダク
ロン布38を装着フレーム40上に破線38として示している。交連ポストアン
カー34及び弁葉線アンカー36は、ダクロンを貫通している。上記の通り、ス
ポット溶接されたアンカーは、ほぼ平面となっているが、内フレームの内面にお
いてわずかだけ(0.003インチが典型的)突出している。結果として、フレ
ームがダクロンにより覆われると、ダクロンの結合面を除いて、内面は平坦とな
る。フレームをダクロンで覆うことにより、フレームの金属などの非生体材料が
身体から隔離される。さらに、組織が布地の間隙から内側へ延びていくのを促進
して、非生体材料を身体から隔離して弁を心臓へ一体化するという目的が達成さ
れる。これは、血栓塞栓症という問題が回避される一助となる。さらに、これに
より、弁の金属及びプラスチック構成部品と組織との間の緩やかな相互作用領域
が提供されて、血液が組織へ自由に流れ得ることにより、組織が養育され、その
生存力が高められる。Since it is difficult to illustrate this cloth in the drawings, FIG.
11B and 11C show the Dacron cloth 38 as a broken line 38 on the mounting frame 40, similar to the sheath 42 and the suturing ring 70 (described below). Commissural post anchors 34 and leaflet anchors 36 extend through the Dacron. As noted above, the spot welded anchor is substantially planar, but only slightly (typically 0.003 inches) protruding from the inner surface of the inner frame. As a result, when the frame is covered with Dacron, the inner surface is flat, except for the Dacron coupling surface. By covering the frame with Dacron, non-living materials such as the metal of the frame are isolated from the body. In addition, the goal of promoting tissue inward from the interstices of the fabric to isolate the non-biomaterial from the body and integrate the valve into the heart is achieved. This helps to avoid the problem of thromboembolism. In addition, this provides a gradual interaction area between the metal and plastic components of the valve and the tissue, allowing blood to flow freely to the tissue, thereby fostering the tissue and increasing its viability. .
【0023】 フレーム用のダクロンカバーは種々の方法で準備することができるが、1つの
有利な方法が、米国特許第5,163,955号に説明されており、このことは
参照により本明細書に組み込まれたものとする。3本指のダクロン靴下または手
袋が、該特許の図4Aに図示及び説明されている。3本指の靴下は、ホットワイ
ヤ技術、ホットソルダリング技術、または超音波技術のいずれかを利用して、ダ
クロン部分をヒートシーミングすることにより形成されている。または、手袋全
体を1つの断片として織るまたは編むことができる。次に、手袋は、(血流から
縫合部を離すために)裏返されて組織フレームにおいて引っ張られ、ヒートシー
ミングにより手袋の基部において固定される。同様の製造方法を、本明細書に説
明した他のダクロンによるカバーに用いることができる。自家組織片 自家組織片50は図7Aに示したような概ね半円形である。この片が形成され
る方法などの詳細について以下に説明する。この組織片50には、図7Aの点線
で示したように、組織弁葉線62に沿い配置された複数の組織固定孔58が形成
されている。組織片の面取り部66は、片を前の片部分に部分的に重ねて配置す
るように確認するために1つの角を切り取るのが好ましい。外科手術により弁を
形成している間に、組織片が、これらの組織孔58により、組み立てられた交連
ポストアンカー34及び弁葉線アンカー36にはめ込まれて、組織フレームに対
して正確に配置される。組織片50を交連ポストアンカーへ装着した様子を図8
に図示した。図示したように、部分的に重なっている組織片50a及び50bは
、組織固定孔58に交連ポストのアンカー34のフック部に挿入した状態にする
ことにより、組織装着フレーム40に装着されている。その結果、2層の組織片
50が、各交連ポストのアンカー34に装着される。ただし、組織片が重なって
いないフレーム下部においては、1枚のみの片が存在している。弁葉線アンカー
36(図8には図示せず)は、フレーム40から外へ大きくは延びていないフッ
ク部を有する。エラストマーシース エラストマーシース42を図9Aに図示する。このエラストマーシースは、組
織装着フレーム40の形状と概ね同様の形状であり、環状のエラストマーシース
基部44と、基部から延びる3本のエラストマーシース交連ポスト46とを有し
ている。エラストマーシース交連ポスト46はエラストマーシーススカラップ状
壁48と連続している。複数のエラストマーシース孔64の位置及び数は、フレ
ーム40の交連ポストアンカー34及び弁葉線アンカー36の位置及び数と一致
している。エラストマーシース42は、ダクロン布で両側を覆われたシリコンゴ
ムから形成されるのが好ましい。While a Dacron cover for a frame can be prepared in various ways, one advantageous method is described in US Pat. No. 5,163,955, which is incorporated herein by reference. Shall be incorporated in A three finger Dacron sock or glove is shown and described in FIG. 4A of the patent. Three-finger socks are formed by heat seaming the Dacron portion using any of the hot wire, hot soldering, or ultrasonic techniques. Alternatively, the entire glove can be woven or knitted as one piece. The glove is then turned upside down (to release the suture from the bloodstream) and pulled in the tissue frame and secured at the base of the glove by heat seaming. Similar manufacturing methods can be used for the other Dacron covers described herein. Self-Tissue Piece The self-tissue piece 50 is substantially semicircular as shown in FIG. 7A. Details such as the method of forming this piece will be described below. As shown by the dotted line in FIG. 7A, the tissue piece 50 has a plurality of tissue fixing holes 58 disposed along the tissue leaflet line 62. The bevel 66 of the tissue piece is preferably cut off at one corner to ensure that the piece is placed partially overlying the previous piece. While forming the valve surgically, the tissue pieces are fitted into the assembled commissure post anchors 34 and leaflet anchors 36 by these tissue holes 58 to be accurately positioned relative to the tissue frame. You. FIG. 8 shows a state in which the tissue piece 50 is attached to the commissure post anchor.
Illustrated in FIG. As shown, the partially overlapping tissue pieces 50a and 50b are mounted on the tissue mounting frame 40 by being inserted into the tissue fixing holes 58 and into the hooks of the anchors 34 of the commissure posts. As a result, two layers of tissue pieces 50 are attached to anchors 34 of each commissure post. However, only one piece exists in the lower part of the frame where the tissue pieces do not overlap. The leaflet anchor 36 (not shown in FIG. 8) has a hook that does not extend significantly out of the frame 40. Elastomer Sheath Elastomer sheath 42 is illustrated in FIG. 9A. The elastomer sheath has a shape substantially similar to the shape of the tissue mounting frame 40, and includes an annular elastomer sheath base 44 and three elastomer sheath commissure posts 46 extending from the base. The elastomeric sheath commissure post 46 is continuous with the elastomeric sheath scalloped wall 48. The positions and numbers of the plurality of elastomeric sheath holes 64 match the positions and numbers of the commissure post anchors 34 and the leaflet line anchors 36 of the frame 40. The elastomer sheath 42 is preferably formed from silicone rubber covered on both sides with a Dacron cloth.
【0024】 エラストマーシース42を、さらに、図9A、図10A、図10B、図10C
、図11A、図11Bに図示している。図10A、図10B、及び図10Cは、
シースは、自家片50のない状態でフレーム40に装着されている所をこれらの
図面に図示しているが、これは図示の目的だけであることに留意されたい。これ
らの片が最初に組織アンカー34、36により組織装着フレーム40に装着され
、その後に初めてシース42が所定位置へ移動されることから、弁の形成中には
このような状態は起こらない。エラストマーシース42の断面は、図9Bに最も
よく図示されているが、エラストマーシース基部44に隣接する2つの縁を有す
る逆向きの「J」字状のようである。エラストマーシース42は、3枚の片を装
着した状態で組み立てられたフレーム構造体に、引っ張り装着されるように設計
されている。図11Bに最もよく図示されているように、エラストマーシース4
2は、組み立てられたフレーム構造体に引っ張られると、組織アンカー34及び
36が、ダクロンに覆われたエラストマーシース孔50内に緩く配置される。The elastomeric sheath 42 is further provided in FIGS. 9A, 10A, 10B, and 10C.
, FIG. 11A and FIG. 11B. 10A, 10B, and 10C are:
It should be noted that the sheath is shown in these figures as being attached to the frame 40 without the self-piece 50, but for illustration purposes only. Such a condition does not occur during the formation of the valve because the pieces are first attached to the tissue attachment frame 40 by the tissue anchors 34, 36, and only then are the sheath 42 moved into position. The cross section of the elastomeric sheath 42, best illustrated in FIG. 9B, appears to be an inverted "J" with two edges adjacent to the elastomeric sheath base 44. The elastomeric sheath 42 is designed to be tensioned to a frame structure assembled with three pieces mounted. As best shown in FIG. 11B, the elastomeric sheath 4
2, when pulled into the assembled frame structure, the tissue anchors 34 and 36 are loosely positioned within the elastomer sheath holes 50 covered by Dacron.
【0025】 逆向き「J」字状の外部エラストマーシースの上面は、フレーム40の交連ポ
スト14の上面に適合している。組織片50は、交連ポストアンカー34及び弁
葉線フック36に装着され、次に、エラストマーシース42の内壁と組織装着フ
レーム40との間の所定位置に保持される。エラストマーシース孔64は、組織
から突出している交連ポストアンカー34及び弁葉線アンカー36のフック部を
収容する。図10Aは、エラストマーシース孔64にはめ込まれた交連ポストア
ンカー34及び弁葉線アンカー36を図示している。The upper surface of the inverted “J” shaped outer elastomeric sheath matches the upper surface of the commissure posts 14 of the frame 40. The tissue piece 50 is mounted on the commissure post anchor 34 and the leaflet line hook 36 and then held in place between the inner wall of the elastomeric sheath 42 and the tissue mounting frame 40. Elastomer sheath holes 64 receive the hooks of commissure post anchors 34 and leaflet anchors 36 that protrude from the tissue. FIG. 10A illustrates commissure post anchors 34 and leaflet anchors 36 fitted in elastomeric sheath holes 64.
【0026】 エラストマーシース42は、フレーム組立体のダクロンカバーに加熱溶接、縫
合、縫い止めすることよって、ダクロンカバーにより基部に対して固定されてい
る。エラストマーシース42は、さらに、逆向き「J」字状の外部シース((図
11B)の上部に配置されたエラストマーシースポケット84により、フレーム
の交連ポスト14の所定位置に保持される。縫合リング 図11A、図11B、図11C、図12A、図12Bに図示したダクロンで覆
われた縫合リング70は、組み立てられた弁の基部に配置されている。縫合リン
グの断面はくさび形であるのが有利で、また他の材料を使用することもできるが
、可撓性、弾性、耐久性のあるシリコンゴムから形成されているのが好ましい。
弁が患者に移植されると縫合リングが大動脈起始部のホタテ貝状に正確に適合す
るように、縫合リングは薄く可撓性がある。The elastomer sheath 42 is secured to the base by the Dacron cover by heat welding, stitching, and stitching to the Dacron cover of the frame assembly. Elastomeric sheath 42 is further an elastomer sheath pocket 84 disposed on the top of the inverted "J" shaped external sheath ((FIG. 11B),. Sewing rings view held in place commissural posts 14 of the frame 11A, 11B, 11C, 12A and 12B, a dacron-covered suture ring 70 is located at the base of the assembled valve, the cross-section of which is advantageously wedge-shaped. Although other materials can be used, it is preferably formed of flexible, elastic and durable silicone rubber.
The suture ring is thin and flexible so that when the valve is implanted in the patient, the suture ring exactly conforms to the scallop of the aortic root.
【0027】 図11B及び図11Cに示したように、縫合リング、組織装着フレーム、及び
エラストマーシースは、加熱溶接点110において全6層のダクロンをともに接
合することにより、連結される。加熱溶接点110は、縫合リングにより、組織
装着フレームとほぼ整列させて形成される。縫合リングが図11Bに示した位置
に移動されると、溶接点は縫合リングと外部シースとの間に隠れる。これにより
、比較的滑らかな溶接面上における血栓塞栓症の発生が防止される。As shown in FIGS. 11B and 11C, the suturing ring, the tissue mounting frame, and the elastomeric sheath are connected by joining all six layers of Dacron together at the heat weld point 110. The heated weld point 110 is formed by the suturing ring substantially aligned with the tissue mounting frame. When the suture ring is moved to the position shown in FIG. 11B, the weld point is hidden between the suture ring and the outer sheath. This prevents thromboembolism from occurring on the relatively smooth weld surface.
【0028】 組織装着フレーム、組織アンカー、及びエラストマーシースは、手術室におけ
る使用に備えて、工場で予め組み立てて、発送することができるすることができ
るキットである。このキットは、工場において組立可能で、エラストマーシース
は組織装着フレームと整合可能である。前述の通り、組織装着フレームのエラス
トマーシースはダクロンで覆われており、ダクロンの層は、図11B及び図11
Cに図示した加熱溶接点110により溶接されるのが好ましい。The tissue mounting frame, tissue anchor, and elastomeric sheath are kits that can be pre-assembled and shipped at the factory for use in the operating room. The kit can be assembled at the factory and the elastomeric sheath can be aligned with the tissue mounting frame. As described above, the elastomer sheath of the tissue mounting frame is covered with Dacron, and the layer of Dacron is
Preferably, welding is performed by a heat welding point 110 shown in FIG.
【0029】 必要に応じて、このキットには、さらに、組織装着フレームのエラストマーシ
ースに装着された縫合リングを含み得る。前述のように、縫合リングも、ダクロ
ンにより覆われ、6枚のダクロン層を加熱溶接点110において溶接することに
より、組織装着フレームのエラストマーシースに装着されるのが、好ましい。自家組織片50の準備 各組織片50の一般的形状を図7Aに図示している。この形状は、弁葉形状と
なるように及び組織にかかる力を最小限にするように設計されたものである。図
2Bに示したように、組織弁葉線94に沿う組織の長さは、組織フレームの弁葉
線長さ30より若干長い。この結果、余分な組織により、カップ形状、すなわち
、婦人服の胸部を形成するように用いられる形状とさほど異ならない隆起部を形
成することができる。弁葉長さに必要とされる以上の組織が多く存在するが、組
織においてひだまたはしわの原因となる程ではない。If desired, the kit may further include a suture ring mounted on the elastomeric sheath of the tissue mounting frame. As described above, the suture ring is also preferably covered by Dacron and attached to the elastomeric sheath of the tissue mounting frame by welding the six Dacron layers at the heat weld point 110. Preparation of Autologous Tissue Piece 50 The general shape of each tissue piece 50 is illustrated in FIG. 7A. This shape is designed to be a leaflet shape and to minimize the force on the tissue. As shown in FIG. 2B, the length of the tissue along the tissue leaflet line 94 is slightly longer than the leaflet line length 30 of the tissue frame. As a result, the excess tissue can form a ridge that is not significantly different from the cup shape, ie, the shape used to form the chest of the women's clothing. There is more tissue than is required for leaflet length, but not enough to cause folds or wrinkles in the tissue.
【0030】 組織片は、最終的な弁の大きさに適合し、またさらに片の片側において組織を
さらに提供するように適合させて、組織切断ダイにより切断されるのが典型的で
ある。自家組織を所定の形状に切断するのに適した切断ダイの例が、米国特許第
5,163,955号明細書及び米国特許第5,425,741号明細書に図示
及び説明されている。好ましい実施形態において、使い捨ての組織切断ダイが、
提供され、使い捨てでない場合もあるハウジングにおいて使用されるだろう。[0030] The tissue piece is typically cut by a tissue cutting die, adapted to the size of the final valve and further adapted to provide more tissue on one side of the piece. Examples of cutting dies suitable for cutting autologous tissue into a predetermined shape are shown and described in U.S. Patent Nos. 5,163,955 and 5,425,741. In a preferred embodiment, the disposable tissue cutting die comprises:
It will be used and will be used in housings that may not be disposable.
【0031】 図11Bにおいて図示したように、切断ダイは、本発明において使用するため
に、交連ポスト14上において覆うのに必要とされる余分の組織を考慮して、組
織片50が切断されるように構成されている。交連ポストにおいて隣接する片(
図11Bの片50a)の上に位置する組織片の部分において、組織片の接合線に
沿う半径は、内側の組織片を覆うのに必要な長さ分だけ余分に長くなっている。
組織切断ダイまたは他の切断装置は、組織片の片側にこのような組織を余分に設
け、また先に配置されている片の上において、片を配置する場所を確認するため
に、切断された片の1つの角を面取りするように、構成されている。組織片の面
取り部66は図7Aに図示している。As shown in FIG. 11B, the cutting die is used to cut the tissue piece 50 to account for the extra tissue needed to cover on the commissure posts 14 for use in the present invention. It is configured as follows. The adjacent piece at the commissure post (
In the portion of the piece of tissue located above the piece 50a) of FIG. 11B, the radius along the joint line of the piece of tissue has been increased by the length necessary to cover the inner piece of tissue.
A tissue cutting die or other cutting device was used to provide such extra tissue on one side of the tissue piece and cut the piece over the previously placed piece to see where to place the piece. It is configured to chamfer one corner of the piece. The bevel 66 of the tissue piece is illustrated in FIG. 7A.
【0032】 上にある組織片の端部の方が長い様子が、図10Cに図示されている。隣接す
る組織片(図11Bにおける片50a)上に位置する組織片の接合線に沿う半径
は、内側の組織片を覆うのに必要とされる長さ分だけ余分に長くなっている。組
織片の中央線から測定した余分の組織は、図7Bにおいて斜線領域98として図
示されている。A longer end of the top piece of tissue is illustrated in FIG. 10C. The radius along the joining line of the tissue piece located on the adjacent tissue piece (piece 50a in FIG. 11B) is extra long by the length needed to cover the inner tissue piece. The extra tissue measured from the center line of the piece of tissue is shown as hatched area 98 in FIG. 7B.
【0033】 組織切断ダイに加えて、組織片を正確に切断するために他の外科手術技術を利
用することができ、例として、ウォータージェット切断装置またはレーザー切断
装置がある。In addition to the tissue cutting die, other surgical techniques can be used to cut tissue pieces accurately, such as a water jet or laser cutting device.
【0034】 本発明の好ましい実施形態の特徴は水平接合線が不要であることである。図1
3に図示したように、このような水平接合線104は、交連ポスト14における
組織へかかる力を非常に増加させる。これは、ある程度の曲率を持つことが許容
される線条と比較した場合において、洗濯物干し綱を非常にピンと張った状態に
維持するのに要する張力に似通っている。本発明の好ましい実施形態により構成
された心臓弁において、外部エラストマーシース42は、組織装着フレーム40
の交連ポスト14近傍の組織片50a及び50bを保持している。接合線に沿う
組織の長さは弁の半径の2倍以上である。組織の延びを考慮すると、この余分の
組織により、交連ポスト角度に対する接合面の角度は図13において102とし
た約65°となる。このように接合角度θが減少したことにより、交連ポスト1
4における組織片にかかる力が非常に低減される。A feature of a preferred embodiment of the present invention is that no horizontal joint lines are required. FIG.
As shown in FIG. 3, such a horizontal joint line 104 greatly increases the force on the tissue at the commissure post 14. This is similar to the tension required to keep a laundry line very taut when compared to a line that is allowed to have some curvature. In a heart valve constructed according to a preferred embodiment of the present invention, the outer elastomeric sheath 42 is
The tissue pieces 50a and 50b near the commissure post 14 are held. The length of the tissue along the joint line is at least twice the radius of the valve. Taking into account the elongation of the tissue, this extra tissue results in an angle of the mating surface relative to the commissure post angle of about 65 °, 102 in FIG. As described above, the joint angle θ is reduced, so that the commissure post 1
The force on the piece of tissue at 4 is greatly reduced.
【0035】 組織片50を構成するための組織は、心膜組織のような自家組織であるのが好
ましいが、大腿筋膜組織、直筋膜組織、静脈組織とすることもできる。これらの
組織源は、全て、比較的もろく取り扱いが難しい。その理由は、一度摘出された
組織の厚さが約10から12ミルとなることである。比較すると、ウシの心膜の
厚さは約15から20ミルである。組織は、摘出された後、通常、0.625%
のグルタルアルデヒド溶液に浸すことより約10分間部分的に硬化させる。これ
により、組織が、丈夫になり取り扱いしやすくなる。The tissue for forming the tissue piece 50 is preferably an autologous tissue such as a pericardial tissue, but may be a femoral fascia tissue, a rectus fascia tissue, or a vein tissue. All of these tissue sources are relatively brittle and difficult to handle. The reason is that the thickness of the tissue once removed is about 10 to 12 mils. By comparison, bovine pericardial thickness is about 15 to 20 mils. Tissues are typically 0.625% after removal
Partially cure for about 10 minutes by soaking in a glutaraldehyde solution. This makes the tissue more robust and easier to handle.
【0036】 自家組織に代わる他の組織源は、ウシの心膜組織または他の異種移植片組織な
どにすることができる。さらに、同種移植片組織とすることが可能である。これ
らの組織は、手術室外部において弁形成者または弁製造者により予め切り取られ
て、従来の方法により保存され得る。ただし、他の組織源を用いる場合、構成要
素の寸法は、その組織を収容するように調節されるが、好ましい組織源より厚い
のが一般的である。外科手術による弁の形成 自家組織のための、洗浄プロセス、摘出プロセス、硬化プロセスが、公知であ
り、例えば、米国特許第5,163,955号明細書に説明されている。[0036] Other sources of tissue that can replace autologous tissue can be bovine pericardial tissue or other xenograft tissue. Further, it can be an allograft tissue. These tissues can be pre-cut by the annuloplasty or valve manufacturer outside the operating room and stored by conventional methods. However, when using other tissue sources, the dimensions of the components are adjusted to accommodate the tissue, but are generally thicker than the preferred tissue source. Irrigation, extraction, and curing processes for surgical valve formation autologous tissue are known and are described, for example, in US Pat. No. 5,163,955.
【0037】 上述のように、硬化に続いて片50が3枚に切り分けられる。As described above, following curing, the piece 50 is cut into three pieces.
【0038】 3枚の片は、切り取り角66(図7A)を有し、部分的に重ねられる寸法であ
り、先に配置された片の上に配置される。これらの片は、布で覆われた組織装着
フレーム40において、組織固定フック34及び36に連続して配置される。The three pieces have a cutout angle 66 (FIG. 7A), are sized to partially overlap, and are placed on top of the previously placed piece. These pieces are placed successively on the tissue fixation hooks 34 and 36 in a tissue mounting frame 40 covered with cloth.
【0039】 次に、エラストマーシース42の各エラストマーシース交連ポスト部46の上
に配置された凹状ポケット84が、組織装着フレーム40の交連ポスト14の上
方で鍵状となるように、エラストマーシース42が、曲げられるかまたは丸めら
れて、フレーム40及び装着された組織片を覆う。好ましい実施形態において、
ダクロンで覆われたエラストマーシースは、組織片が図1に示した自然閉鎖弁を
形成するように、弁葉線(図11Cを参照)の近傍において組織片に緩く載って
いる。シース42により、組織片50が組織固定フック34及び36から外れる
ことが防止され、シースは、図10Cに図示したように、交連ポスト14の上部
とそこに装着された組織片を、実質的に取り囲み、「抱きかかえている」。この
結果、隣接する片は相互に接合線で接触している。Next, the elastomeric sheath 42 is positioned such that the concave pocket 84 disposed on each of the elastomeric sheath commissure posts 46 of the elastomeric sheath 42 is keyed above the commissure posts 14 of the tissue mounting frame 40. Bent or rolled over to cover the frame 40 and the mounted piece of tissue. In a preferred embodiment,
The elastomer sheath covered with Dacron rests loosely on the tissue piece near the leaflet line (see FIG. 11C) so that the piece forms the natural closure valve shown in FIG. The sheath 42 prevents the piece of tissue 50 from disengaging from the tissue fixation hooks 34 and 36, and the sheath substantially removes the top of the commissure post 14 and the piece of tissue attached thereto, as shown in FIG. 10C. Surrounding, "I'm holding you." As a result, the adjacent pieces are in contact with each other at the joining line.
【0040】 先行技術の教示により、完成した弁は、試験されて、次に移植用のホルダーに
装着される。例えば、米国特許第5,163,955号を参照されたい。According to the teachings of the prior art, the completed valve is tested and then mounted in a holder for implantation. See, for example, U.S. Patent No. 5,163,955.
【図1】 本発明による構成の組み立てられた自家組織心臓弁の好ましい実施形態を示す
斜視図である。FIG. 1 is a perspective view of a preferred embodiment of an assembled autologous heart valve in a configuration according to the present invention.
【図2A】 製造途中の、組織装着フレームの内フレーム部を図示した正面図である。FIG. 2A is a front view illustrating an inner frame portion of a tissue mounting frame during manufacturing.
【図2B】 製造途中の、組織装着フレームの外フレーム部を図示した正面図である。FIG. 2B is a front view illustrating an outer frame portion of the tissue mounting frame during manufacturing.
【図3A】 フレームが円筒形に巻かれた後の外フレームを図示した斜視図である。FIG. 3A is a perspective view illustrating the outer frame after the frame is wound into a cylindrical shape.
【図3B】 同心に連結された内フレームと外フレームとを図示する斜視図である。FIG. 3B is a perspective view illustrating an inner frame and an outer frame connected concentrically.
【図3C】 組織アンカーを伴って完成した布により覆われる前の組織装着フレームを図示
する斜視図である。FIG. 3C is a perspective view illustrating the tissue mounting frame before being covered by the finished fabric with the tissue anchor.
【図3D】 交連ポストアンカーのうちの1本を拡大して図示する斜視図である。FIG. 3D is an enlarged perspective view of one of the commissure post anchors.
【図4】 交連組織アンカーの拡大図である。FIG. 4 is an enlarged view of a commissure tissue anchor.
【図5】 弁葉組織アンカーの拡大図である。FIG. 5 is an enlarged view of a leaflet tissue anchor.
【図6】 図3Cの6−6線に沿う断面図である。FIG. 6 is a cross-sectional view taken along line 6-6 of FIG. 3C.
【図7A】 自家組織片のうちの1枚の正面図である。FIG. 7A is a front view of one of the autologous tissue pieces.
【図7B】 交連フック上の組織片を部分的に覆うための余分の組織を図示する、図7Aの
自家組織片の正面図である。FIG. 7B is a front view of the autologous tissue piece of FIG. 7A illustrating extra tissue to partially cover the tissue piece on the commissure hook.
【図8】 部分的に重なっている2枚の自家組織片をさらに伴う図6の断面図である。FIG. 8 is a cross-sectional view of FIG. 6 further with two partially overlapping autologous tissue pieces.
【図9A】 エラストマーシースの斜視図である。FIG. 9A is a perspective view of an elastomeric sheath.
【図9B】 図9Aの9B−9B線に沿う断面図である。FIG. 9B is a sectional view taken along line 9B-9B in FIG. 9A.
【図10A】 組織装着フレームに取り付けられたエラストマーシースの斜視図である。FIG. 10A is a perspective view of an elastomeric sheath attached to a tissue mounting frame.
【図10B】 図10Aに図示したエラストマーシースの正面図である。FIG. 10B is a front view of the elastomeric sheath shown in FIG. 10A.
【図10C】 図1の10C−10C線に沿う断面図である。FIG. 10C is a sectional view taken along line 10C-10C in FIG. 1;
【図11A】 図1の11A−11A線に沿う断面図である。11A is a sectional view taken along the line 11A-11A in FIG. 1;
【図11B】 図1の11B−11B線に沿う断面図である。11B is a sectional view taken along the line 11B-11B in FIG.
【図11C】 図1の11C−11C線に沿う断面図である。11C is a sectional view taken along the line 11C-11C in FIG.
【図12A】 布で覆われる前の管状縫合リングの斜視図である。FIG. 12A is a perspective view of a tubular suture ring before being covered with a cloth.
【図12B】 図12Aの12B−12B線に沿う断面図である。FIG. 12B is a sectional view taken along line 12B-12B in FIG. 12A.
【図13】 本発明の好ましい実施形態における低減された接合角度θを図示する図である
。FIG. 13 illustrates a reduced joint angle θ in a preferred embodiment of the present invention.
【手続補正書】[Procedure amendment]
【提出日】平成13年5月7日(2001.5.7)[Submission date] May 7, 2001 (2001.5.7)
【手続補正1】[Procedure amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0016[Correction target item name] 0016
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0016】 交連ポストのアンカー34(図4)及び弁葉線のアンカー36(図5)は、金
属、好ましくはエルジロイから製造される。このアンカー34はフック部34a
を含み、またアンカー36は突起部36aを含み、フック部34a及び突起部3
6aは、アンカーを組織装着フレーム40に恒久的に取り付けるために用いられ
ている。円筒であり、内フレーム孔20及び外フレーム孔26を介して連結され
た内フレーム及び外フレームの内側から、フック部が挿入されて、(図3C及び
図3Bに図示したように)フック部が外フレーム面の外側に延びている。突起部
36aは、内フレーム10に配置され、より大きい対応の内フレーム孔20を通
って、外フレーム24の内面にスポット溶接される。図6にもっともよく図示さ
れているように、突起部34aは、外フレーム24の内面に隣接しており、より
大きい対応の内フレーム孔20内に位置する。以下に明らかとなるだろうが、図
4及び図5に図示したように、交連ポストのアンカー34は、弁葉線アンカー用
に1層というより2層の組織を保持するために、弁葉線アンカー36より若干長
い。The commissure post anchors 34 (FIG. 4) and the leaflet anchors 36 (FIG. 5) are manufactured from metal, preferably Elgiloy. This anchor 34 is a hook portion 34a
And the anchor 36 includes a protrusion 36a, the hook 34a and the protrusion 3a.
6a is used to permanently attach the anchor to the tissue mounting frame 40. Hooks are inserted from the inside of the inner and outer frames, which are cylindrical and connected via the inner and outer frame holes 20 and 26, to engage the hooks (as shown in FIGS. 3C and 3B). It extends outside the outer frame surface. The protrusion 36 a is disposed on the inner frame 10 and is spot-welded to the inner surface of the outer frame 24 through the corresponding inner frame hole 20. As best shown in FIG. 6, the protrusion 34a is adjacent to the inner surface of the outer frame 24 and is located within a larger corresponding inner frame hole 20. As will become apparent below, as shown in FIGS. 4 and 5, the commissure post anchors 34 are used to hold two layers of tissue rather than one layer for leaflet anchors. Slightly longer than anchor 36.
【手続補正2】[Procedure amendment 2]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0020[Correction target item name] 0020
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0020】 図6は、内フレーム10、外フレーム24、及び交連ポストアンカー34を示
す、組み立てられた組織装着フレーム40の片側から見た断面図である。2つの
交連ポストアンカー34は、内フレーム孔20を通り、外フレーム24の内壁に
溶接されている。図示してはいないが、弁葉線アンカー36も同様にフレーム4
0の下部に溶接されている。FIG. 6 is a cross-sectional view from one side of the assembled tissue mounting frame 40 showing the inner frame 10, outer frame 24, and commissure post anchors 34. The two commissure post anchors 34 pass through the inner frame hole 20 and are welded to the inner wall of the outer frame 24. Although not shown, the leaflet line anchor 36 is similarly connected to the frame 4.
0 is welded to the lower part.
【手続補正3】[Procedure amendment 3]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0024[Correction target item name] 0024
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0024】 エラストマーシース42を、さらに、図9A、図10A、図10B、図10C
、図11A、図11Bに図示している。図10A、図10B、及び図10Cは、
シースは、自家片50のない状態でフレーム40に装着されている所をこれらの
図面に図示しているが、これは図示の目的だけであることに留意されたい。これ
らの片が最初に組織アンカー34、36により組織装着フレーム40に装着され
、その後に初めてシース42が所定位置へ移動されることから、弁の形成中には
このような状態は起こらない。エラストマーシース42の断面は、図9Bに最も
よく図示されているが、エラストマーシース基部44に隣接する2つの縁を有す
る逆向きの「J」字状のようである。エラストマーシース42は、3枚の片を装
着した状態で組み立てられたフレーム構造体に、引っ張り装着されるように設計
されている。図11Bに最もよく図示されているように、エラストマーシース4
2は、組み立てられたフレーム構造体に引っ張られると、組織アンカー34及び
36が、ダクロンに覆われたエラストマーシース孔64内に緩く配置される。The elastomeric sheath 42 is further provided in FIGS. 9A, 10A, 10B, and 10C.
, FIG. 11A and FIG. 11B. 10A, 10B, and 10C are:
It should be noted that the sheath is shown in these figures as being attached to the frame 40 without the self-piece 50, but for illustration purposes only. Such a condition does not occur during the formation of the valve because the pieces are first attached to the tissue attachment frame 40 by the tissue anchors 34, 36, and only then are the sheath 42 moved into position. The cross section of the elastomeric sheath 42, best illustrated in FIG. 9B, appears to be an inverted "J" with two edges adjacent to the elastomeric sheath base 44. The elastomeric sheath 42 is designed to be tensioned to a frame structure assembled with three pieces mounted. As best shown in FIG. 11B, the elastomeric sheath 4
2, when pulled into the assembled frame structure, the tissue anchors 34 and 36 are loosely positioned within the elastomer sheath holes 64 covered by Dacron.
【手続補正4】[Procedure amendment 4]
【補正対象書類名】図面[Document name to be amended] Drawing
【補正対象項目名】図10C[Correction target item name] FIG. 10C
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【図10C】 FIG. 10C
───────────────────────────────────────────────────── フロントページの続き (81)指定国 EP(AT,BE,CH,CY, DE,DK,ES,FI,FR,GB,GR,IE,I T,LU,MC,NL,PT,SE),OA(BF,BJ ,CF,CG,CI,CM,GA,GN,GW,ML, MR,NE,SN,TD,TG),AP(GH,GM,K E,LS,MW,SD,SL,SZ,TZ,UG,ZW ),EA(AM,AZ,BY,KG,KZ,MD,RU, TJ,TM),AE,AL,AM,AT,AU,AZ, BA,BB,BG,BR,BY,CA,CH,CN,C R,CU,CZ,DE,DK,DM,EE,ES,FI ,GB,GD,GE,GH,GM,HR,HU,ID, IL,IN,IS,JP,KE,KG,KP,KR,K Z,LC,LK,LR,LS,LT,LU,LV,MD ,MG,MK,MN,MW,MX,NO,NZ,PL, PT,RO,RU,SD,SE,SG,SI,SK,S L,TJ,TM,TR,TT,TZ,UA,UG,US ,UZ,VN,YU,ZA,ZW (72)発明者 トンプキンス デイビッド イギリス ケーティー12 2エヌエー サ リー ワルトン−オン−テームズ シドニ ー ロード 24エー (72)発明者 ヘムズレイ デイビッド イギリス ダブリューディー3 2エヌワ イ ハーツ リクマンズワース ヒル ラ イズ 23 Fターム(参考) 4C097 AA27 BB01 CC01 DD04 EE08──────────────────────────────────────────────────続 き Continuation of front page (81) Designated country EP (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE ), OA (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG), AP (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW), EA (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID , IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW (72) Invention Tompkins David United Kingdom Katie 12 2NA Walton-On-Thames Sidney Road 24A (72) Inventor Hemsley David United Kingdom Drewdy 3 2NN Hearts Rickmansworth Hill Rise 23 F-term (reference) 4C097 AA27 BB01 CC01 DD04 EE08
Claims (45)
固定フックとを有する組織装着フレームと、 前記組織装着フレームに取り付けられた縫合リングと、 前記組織装着フレームに取り付けられたエラストマーシースとを有して製造さ
れたサブ組立体と、 (b)外科手術により複数の装着開口部を伴い切断された3枚の自家組織片と
を備え、 前記組織片は、各組織固定フックに装着されることにより、1本の交連ポスト
から隣接する交連ポストへ延び、各交連ポストにおいて隣接した前の片に部分的
に重なった状態で、前記組織装着フレームの周囲を取り囲んで連続して配置され
、 前記エラストマーシースは、(i)前記組織片が前記組織固定フックから外れ
ないように、前記片上に緩く載っており、また(ii)前記片が弁葉を形成する
ように、前記交連ポストと該ポストに取り付けられた前記組織片とを取り囲んで
いる組織心臓弁。1. A tissue mounting frame comprising: (a) a tissue mounting frame having a generally cylindrical base, three commissure posts, and a plurality of outwardly projecting tissue fixation hooks; A subassembly having a suture ring attached to the tissue mounting frame and an elastomeric sheath attached to the tissue mounting frame; and (b) three subcutaneous cuts with a plurality of mounting openings by surgery. An autologous tissue piece, wherein the tissue piece extends from one commissure post to an adjacent commissure post by being attached to each tissue fixing hook, and partially overlaps an adjacent previous piece at each commissure post. And the elastomer sheath is arranged continuously around the periphery of the tissue mounting frame in the closed state, wherein the (i) the tissue piece does not come off the tissue fixing hook. A tissue heart valve resting loosely and (ii) surrounding the commissure post and the piece of tissue attached to the post such that the piece forms a leaflet.
固定フックとを有する組織装着フレームと、 前記組織装着フレームに取り付けられた縫合リングと、 前記組織装着フレームに取り付けられたエラストマーシースとを有して製造さ
れたサブ組立体と、 (b)外科手術により切断された3枚の自家組織片とを備え、該組織片は、 (i)概ね半円形で、 (ii)前記組織弁葉線に沿う組織の長さが前記組織装着フレームの弁葉線の
長さより若干長いので、前記余分の組織により、前記片が前記組織装着フレーム
に装着されると弁葉形を形成可能であり、 (iii)前記組織装着フレームの前記交連ポストにおいて、隣接する片に前
記組織を部分的に重ねて収容するように、各片の片側において備えられた余分の
組織を有し、 (iv)前記組織片が前記組織装着フレームに及び前記エラストマーシース内
に装着されると、隣接する組織片の自由縁により画定される接合線が水平線とな
らないように十分な組織をさらに有し、 (v)複数の装着開口部を有し、 前記組織片の前記開口部が別々に前記組織固定フックにはめ込まれることによ
り、前記片は前記組織装着フレームの周囲を取り囲んで連続して装着され、また
前記各片は前記交連ポストから隣接する交連ポストへ延び、 前記エラストマーシースが前記組織片において折り曲げられることにより、前
記エラストマーシースは、 (i)前記固定フックから前記組織片が外れないように前記片に緩く載り、及
び (ii)前記交連ポストと該交連ポストに取り付けられた組織片の上部とを取
り囲むことにより、(i)前記片が弁葉を形成し、(ii)隣接する片が前記接
合線に沿い相互に接触する組織心臓弁。2. A tissue mounting valve comprising: (a) a tissue mounting frame having a generally cylindrical base, three commissure posts, and a plurality of outwardly projecting tissue fixation hooks; A suture ring attached to the tissue mounting frame, and a subassembly manufactured having an elastomeric sheath attached to the tissue mounting frame; and (b) three autologous tissue pieces cut by surgery. The tissue piece is (i) substantially semicircular, and (ii) the length of the tissue along the tissue leaflet line is slightly longer than the length of the leaflet line of the tissue mounting frame. A leaflet shape can be formed when a piece is mounted on the tissue mounting frame; and (iii) at the commissure posts of the tissue mounting frame, the tissue is partially overlapped and accommodated on adjacent pieces. Each piece (Iv) when the tissue piece is mounted on the tissue mounting frame and within the elastomeric sheath, the joining line defined by the free edges of adjacent tissue pieces is horizontal. (V) having a plurality of mounting openings, wherein the openings of the tissue pieces are separately fitted into the tissue fixing hooks, whereby the pieces are mounted on the tissue. The pieces are continuously attached around a frame, and each piece extends from the commissure post to an adjacent commissure post, and the elastomeric sheath is bent at the tissue piece so that the elastomeric sheath comprises: Loosely resting on the piece so that the piece of tissue does not come off the fixation hook; and (ii) attached to the commissure post and the commissure post A tissue heart valve wherein (i) the pieces form leaflets and (ii) adjacent pieces contact each other along the junction line by surrounding the top of the piece.
固定フックとを有する組織装着フレームと、 前記組織装着フレームに取り付けられた縫合リングと、 前記組織装着フレームに取り付けられたエラストマーシースとを有するサブ組
立体と、 (b)複数の組織片とを備え、 前記組織片は、外科手術により切断され、別個の組織アンカーにより保持され
ることにより、各組織片が、1本の交連ポストから隣接する交連ポストへ延びた
状態で、前記組織装着フレームの周囲を取り囲み連続して配置され、また前記エ
ラストマーシースが、 (i)前記組織アンカーに対して前記組織片を維持するように前記片に緩く載
っており、 (ii)前記組織片が弁葉を形成するように、前記交連ポストと該交連ポスト
に取り付けられた前記片の上部を取り囲んでいる組織心臓弁。3. A tissue mounting frame comprising: (a) a tissue mounting frame having a generally cylindrical base, three commissure posts, and a plurality of outwardly projecting tissue fixation hooks; A sub-assembly having a suture ring attached to the tissue mounting frame; and (b) a plurality of pieces of tissue, wherein the pieces of tissue are surgically cut and separated. By being retained by the tissue anchor, each piece of tissue is disposed continuously around the tissue mounting frame, with each piece extending from one commissure post to an adjacent commissure post, and the elastomeric sheath is (I) resting loosely on the piece so as to maintain the piece of tissue with respect to the tissue anchor; Tissue heart valve surrounding the upper portion of the piece which is attached to the posts and said cross connecting post.
ムを含む請求項3に記載の組織心臓弁。4. The tissue heart valve according to claim 3, wherein the tissue mounting frame includes an inner frame fixed to an outer frame.
サイズとされている請求項3に記載の組織心臓弁。5. The tissue heart valve of claim 3, wherein the piece of tissue is oversized to promote the formation of the leaflets.
の接合角度を伴って、前記複数の組織片を保持するように、前記組織片は大きめ
のサイズとされている請求項3に記載の組織心臓弁。6. The tissue piece is oversized so that the elastomeric sheath holds the plurality of tissue pieces with a physiologically similar joining angle of less than 90 °. A tissue heart valve according to claim 1.
に記載の心臓弁。7. The method of claim 6, wherein said joint angle to the commissure post is about 65 °.
A heart valve according to claim 1.
対して均等な力がかかるように調節を行う請求項3に記載の心臓弁。8. The heart valve according to claim 3, wherein the elastomer sheath itself adjusts so as to exert an even force on the tissue piece of the frame.
ースは前記フックを収容する複数の孔を有する請求項3に記載の心臓弁。9. The heart valve of claim 3, wherein the tissue anchor is a hook and the elastomeric sheath has a plurality of holes for receiving the hook.
を収容する請求項9に記載の心臓弁。10. The heart valve of claim 9, wherein an opening in the elastomeric sheath accommodates an outer portion of the hook.
ームと整合される請求項3に記載の心臓弁。11. The heart valve of claim 3, wherein the elastomeric sheath is aligned with the tissue mounting frame at the factory.
装着開口部と、(ii)前記外側のエラストマーシースと前記内側の組織装着フ
レームとの間の前記組織片の外周部と係合している前記エラストマーシースとを
組み合わせることにより、2つの柔軟性のない部材の間において前記組織を締め
付けずに、前記組織片が支持及び保持される請求項3に記載の心臓弁。12. The perimeter of the tissue piece between (i) the mounting opening of the piece separately fitted in the tissue anchor, and (ii) the outer elastomeric sheath and the inner tissue mounting frame. 4. The heart valve according to claim 3, wherein the combination of the elastomeric sheath with a mating portion supports and retains the tissue piece without clamping the tissue between two inflexible members. .
に記載の心臓弁。13. The tissue piece is a partially hardened autologous tissue.
A heart valve according to claim 1.
項3に記載の心臓弁。14. The heart valve according to claim 3, wherein the piece of tissue is partially hardened autologous pericardial tissue.
記載の心臓弁。15. The heart valve according to claim 3, wherein the tissue mounting frame is covered with a cloth.
記載の心臓弁。16. The heart valve according to claim 15, wherein the cloth is polyethylene terephthalate.
療装置及び前記組織を収容して、該組織を前記医療装置に保持する、柔らかで可
撓性がある環状の本体を有するシース。17. A soft, flexible, annular body for securing tissue to a medical device, the sheath containing the medical device and the tissue, and retaining the tissue to the medical device. Having a sheath.
ックを収容するための複数の孔を有する請求項17に記載のシース。18. The sheath according to claim 17, wherein the sheath has a plurality of holes in the annular body for receiving hooks in the medical device.
記組織アンカーにおいて保持する心臓弁。19. A heart valve, comprising: a frame having an annular base, a plurality of posts extending from the base, a plurality of tissue anchors attached to the frame, and a plurality of tissues held by the tissue anchor. A heart valve comprising a piece and a flexible elastomeric sheath, wherein the sheath is adapted to the frame and the piece of tissue and retains the piece of tissue at the tissue anchor.
ら延びる複数のポストとを備える請求項19に記載の心臓弁。20. The heart valve according to claim 19, wherein the elastomeric sheath comprises an annular base and a plurality of posts extending from the annular base.
フレームの複数のフックにおいて保持される請求項19に記載の心臓弁。21. The heart valve of claim 19, wherein the tissue anchor is a hook and the piece of tissue is retained on a plurality of hooks of the frame.
求項19に記載の心臓弁。22. The heart valve according to claim 19, wherein the frame includes an inner frame and an outer frame.
ーム及び外フレームを含む請求項19に記載の心臓弁。23. The heart valve of claim 19, wherein the frame includes an inner frame and an outer frame connected near the base.
サイズとされている請求項19に記載の心臓弁。24. The heart valve of claim 19, wherein the piece of tissue is oversized to promote the formation of the leaflets.
複数の組織片を保持する請求項19に記載の心臓弁。25. The heart valve of claim 19, wherein the elastomeric sheath holds the plurality of pieces at a joint angle of less than 90 °.
組織片に対して均等な力がかかるように調整を行う請求項19に記載の心臓弁。26. The heart valve of claim 19, wherein the elastomeric sheath itself adjusts the frame to apply an equal force to the tissue piece.
を有する請求項21に記載の心臓弁。27. The heart valve according to claim 21, wherein the elastomeric sheath has a plurality of holes for receiving the hooks.
ームに保持されている請求項19に記載の心臓弁。28. The heart valve of claim 19, wherein the sheath is held in the post by a pocket at the frame.
合される請求項19に記載の心臓弁。29. The heart valve of claim 19, wherein the elastomeric sheath is aligned with the frame at the factory.
外周部と係合している前記エラストマーシースとを組み合わせることにより、前
記2つの柔軟性のない部材の間において前記組織を締め付けずに、支持及び保持
されている請求項19に記載の心臓弁。30. The tissue piece comprising: (i) the tissue anchor; and (ii) the elastomeric sheath engaged with the outer periphery of the tissue piece between the elastomer sheath and the frame. 20. The heart valve of claim 19, wherein the heart valve is supported and retained without clamping the tissue between the two inflexible members.
9に記載の心臓弁。31. The tissue piece is a partially hardened autologous tissue.
10. The heart valve according to 9.
項19に記載の心臓弁。32. The heart valve according to claim 19, wherein the piece of tissue is partially hardened autologous pericardial tissue.
心臓弁。33. The heart valve according to claim 19, wherein the frame is covered by a cloth.
記載の心臓弁。34. The heart valve according to claim 33, wherein the cloth is polyethylene terephthalate.
載の心臓弁。35. The heart valve of claim 19, further comprising a flexible annular suture ring.
フレームに取り付けられる請求項35に記載の心臓弁。36. The heart valve of claim 35, wherein the elastomeric sheath and the annular suture ring are attached to the frame.
ムに取り付けられる請求項19に記載の心臓弁。37. The heart valve of claim 19, wherein the piece of tissue is surgically attached to the frame during a valve replacement procedure.
シースとを備え、 前記ポストは、前記装着フレームに前記シースを保持するためのポケットを有
する、心臓弁を形成するためのキット。38. A kit for forming a heart valve, comprising: an annular base; a mounting frame having a plurality of posts extending from the base; a plurality of fixed hooks attached to the mounting frame; A flexible elastomeric sheath including a plurality of posts extending from the base, the post having a pocket in the mounting frame for retaining the sheath.
られた縫合リングをさらに備える請求項38に記載のキット。39. The kit of claim 38, further comprising a suture ring attached to said mounting frame and said elastomeric sheath.
載の器具。40. The device of claim 38, wherein said mounting frame is covered by a cloth.
数のフックとを有する前記フレームを準備し、 前記フックに前記組織の孔を配置することにより、前記組織片を前記フレーム
に取り付け、 前記組織片を心臓弁葉に形成するように、前記フレームのポストにおいて、前
記ポストと該ポストに取り付けられた前記片部分とを取り囲むように、エラスト
マーシースを折り曲げることを含む心臓弁組立方法。41. A method for assembling a heart valve, comprising cutting tissue from a patient, cutting the tissue into a piece of tissue having a plurality of holes, an annular base, a plurality of posts extending from the base, and a frame. Preparing the frame having a plurality of hooks attached to the hook, and arranging a hole of the tissue in the hook to attach the tissue piece to the frame, so that the tissue piece is formed in a heart valve leaflet. A method of assembling a heart valve, comprising bending an elastomeric sheath around a post of the frame and the piece attached to the post.
数の組織アンカーとを有するフレームに、前記複数の組織片を取り付け、 前記片を前記フレームにおいて保持するように、前記フレーム及び前記組織片
においてエラストマーシースを折り曲げることを含む心臓弁を組み立てる方法。42. A method of assembling a heart valve, comprising cutting a tissue into a plurality of pieces of tissue, the frame having an annular base, a plurality of posts extending from the base, and a plurality of tissue anchors attached to the frame. A method of assembling a heart valve comprising attaching the plurality of pieces of tissue to the frame and folding an elastomeric sheath in the frame and the piece of tissue to hold the pieces in the frame.
ーとを有する組織装着フレームと、 前記組織装着フレームに取り付けられた縫合リングと、 前記組織装着フレームに取り付けられたエラストマーシースとを備える、組織
心臓弁を形成するためのサブ組立体。43. A subassembly for forming a tissue heart valve, comprising: a tissue mounting frame having a generally cylindrical base, a plurality of commissure posts, and a plurality of outwardly projecting tissue anchors; A subassembly for forming a tissue heart valve, comprising: a suture ring attached to a tissue attachment frame; and an elastomeric sheath attached to the tissue attachment frame.
トマーシースであって、 前記シースは、環状基部と、該基部から延びる複数のポストとを有し、 前記シースは、柔らかく可撓性がある材料から形成されており、また前記装着
フレームのフックを収容するための複数の孔を有する、組織片を装着フレームに
固定するためのエラストマーシース。44. An elastomeric sheath for securing a piece of tissue to a heart valve tissue mounting frame, the sheath having an annular base and a plurality of posts extending from the base, wherein the sheath is soft and flexible. An elastomeric sheath for securing a piece of tissue to a mounting frame, the elastomeric sheath being formed from a flexible material and having a plurality of holes for receiving hooks of the mounting frame.
求項44に記載のエラストマーシース。45. The elastomeric sheath of claim 44, wherein the cross section of the elastomeric sheath is inverted "J" shaped.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/161,809 US6334873B1 (en) | 1998-09-28 | 1998-09-28 | Heart valve having tissue retention with anchors and an outer sheath |
US09/161,809 | 1998-09-28 | ||
PCT/US1999/021997 WO2000018333A1 (en) | 1998-09-28 | 1999-09-22 | Heart valve having tissue retention with anchors and an outer sheath |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002525169A true JP2002525169A (en) | 2002-08-13 |
Family
ID=22582838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000571856A Pending JP2002525169A (en) | 1998-09-28 | 1999-09-22 | Heart valve with tissue and outer sheath secured by anchor |
Country Status (6)
Country | Link |
---|---|
US (2) | US6334873B1 (en) |
EP (1) | EP1117354A1 (en) |
JP (1) | JP2002525169A (en) |
CN (1) | CN1328436A (en) |
AU (1) | AU6259499A (en) |
WO (1) | WO2000018333A1 (en) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010524632A (en) * | 2007-04-26 | 2010-07-22 | セント ジュード メディカル インコーポレイテッド | Technique for attaching a flexible leaflet of a prosthetic heart valve to a support structure |
US7896913B2 (en) | 2000-02-28 | 2011-03-01 | Jenavalve Technology, Inc. | Anchoring system for implantable heart valve prostheses |
JP2012521222A (en) * | 2009-03-19 | 2012-09-13 | ミリピード リミテッド ライアビリティー カンパニー | Reconstruction of cardiac features |
USRE45130E1 (en) | 2000-02-28 | 2014-09-09 | Jenavalve Technology Gmbh | Device for fastening and anchoring cardiac valve prostheses |
US9180005B1 (en) | 2014-07-17 | 2015-11-10 | Millipede, Inc. | Adjustable endolumenal mitral valve ring |
US9192471B2 (en) | 2007-01-08 | 2015-11-24 | Millipede, Inc. | Device for translumenal reshaping of a mitral valve annulus |
US9510947B2 (en) | 2011-10-21 | 2016-12-06 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient |
US9795480B2 (en) | 2010-08-24 | 2017-10-24 | Millipede, Inc. | Reconfiguring tissue features of a heart annulus |
JP2017538518A (en) * | 2014-12-18 | 2017-12-28 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Prosthetic valve with mechanically coupled leaflets |
US9867694B2 (en) | 2013-08-30 | 2018-01-16 | Jenavalve Technology Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US9878127B2 (en) | 2012-05-16 | 2018-01-30 | Jenavalve Technology, Inc. | Catheter delivery system for heart valve prosthesis |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
JP2021500977A (en) * | 2017-10-31 | 2021-01-14 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Surgical heart valve jacket |
JP2021037378A (en) * | 2014-12-18 | 2021-03-11 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Prosthetic valves with mechanically coupled leaflets |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US11439502B2 (en) | 2017-10-31 | 2022-09-13 | W. L. Gore & Associates, Inc. | Medical valve and leaflet promoting tissue ingrowth |
US11471276B2 (en) | 2014-09-15 | 2022-10-18 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US11826248B2 (en) | 2012-12-19 | 2023-11-28 | Edwards Lifesciences Corporation | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US11857412B2 (en) | 2017-09-27 | 2024-01-02 | Edwards Lifesciences Corporation | Prosthetic valve with expandable frame and associated systems and methods |
US11872122B2 (en) | 2012-12-19 | 2024-01-16 | Edwards Lifesciences Corporation | Methods for improved prosthetic heart valve with leaflet shelving |
US11896481B2 (en) | 2012-12-19 | 2024-02-13 | Edwards Lifesciences Corporation | Truncated leaflet for prosthetic heart valves |
US11950999B2 (en) | 2012-07-25 | 2024-04-09 | Edwards Lifesciences Corporation | Everting transcatheter valve and methods |
US11986387B2 (en) | 2017-09-27 | 2024-05-21 | Edwards Lifesciences Corporation | Prosthetic valves with mechanically coupled leaflets |
US12059344B2 (en) | 2017-09-12 | 2024-08-13 | Edwards Lifesciences Corporation | Leaflet frame attachment for prosthetic valves |
US12064344B2 (en) | 2017-10-13 | 2024-08-20 | Edwards Lifesciences Corporation | Telescoping prosthetic valve and delivery system |
US12115063B2 (en) | 2012-07-27 | 2024-10-15 | Edwards Lifesciences Corporation | Multi-frame prosthetic valve apparatus and methods |
US12121461B2 (en) | 2016-03-17 | 2024-10-22 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath |
Families Citing this family (273)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US6736845B2 (en) * | 1999-01-26 | 2004-05-18 | Edwards Lifesciences Corporation | Holder for flexible heart valve |
US6589279B1 (en) * | 1999-04-28 | 2003-07-08 | St. Jude Medical, Inc. | Efficient implantation of heart valve prostheses |
US6626899B2 (en) * | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US6991643B2 (en) | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
US7195641B2 (en) * | 1999-11-19 | 2007-03-27 | Advanced Bio Prosthetic Surfaces, Ltd. | Valvular prostheses having metal or pseudometallic construction and methods of manufacture |
US6458153B1 (en) | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US6709457B1 (en) * | 1999-11-24 | 2004-03-23 | St. Jude Medical, Inc. | Attachment of suture cuff to prosthetic heart valve |
US6872226B2 (en) * | 2001-01-29 | 2005-03-29 | 3F Therapeutics, Inc. | Method of cutting material for use in implantable medical device |
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US8366769B2 (en) | 2000-06-01 | 2013-02-05 | Edwards Lifesciences Corporation | Low-profile, pivotable heart valve sewing ring |
US6409758B2 (en) * | 2000-07-27 | 2002-06-25 | Edwards Lifesciences Corporation | Heart valve holder for constricting the valve commissures and methods of use |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US7556646B2 (en) | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
FR2828263B1 (en) | 2001-08-03 | 2007-05-11 | Philipp Bonhoeffer | DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE |
US7097659B2 (en) * | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US7201771B2 (en) | 2001-12-27 | 2007-04-10 | Arbor Surgical Technologies, Inc. | Bioprosthetic heart valve |
US8308797B2 (en) | 2002-01-04 | 2012-11-13 | Colibri Heart Valve, LLC | Percutaneously implantable replacement heart valve device and method of making same |
US6752828B2 (en) * | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
WO2003092554A1 (en) * | 2002-05-03 | 2003-11-13 | The General Hospital Corporation | Involuted endovascular valve and method of construction |
US8348963B2 (en) * | 2002-07-03 | 2013-01-08 | Hlt, Inc. | Leaflet reinforcement for regurgitant valves |
US7959674B2 (en) * | 2002-07-16 | 2011-06-14 | Medtronic, Inc. | Suture locking assembly and method of use |
US20040092858A1 (en) | 2002-08-28 | 2004-05-13 | Heart Leaflet Technologies, Inc. | Leaflet valve |
FR2846639B1 (en) * | 2002-11-06 | 2004-12-10 | Innovation Packaging | PACKAGING AND DISPENSING DEVICE FOR A LIQUID OR SEMI-LIQUID PRODUCT |
EP1558332A2 (en) | 2002-11-07 | 2005-08-03 | Axiom Medical Inc. | Epicardial heartwire, chest tube with epicardial heartwire, and method of use |
US8551162B2 (en) | 2002-12-20 | 2013-10-08 | Medtronic, Inc. | Biologically implantable prosthesis |
US8021421B2 (en) * | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US20050075725A1 (en) | 2003-10-02 | 2005-04-07 | Rowe Stanton J. | Implantable prosthetic valve with non-laminar flow |
US7556647B2 (en) * | 2003-10-08 | 2009-07-07 | Arbor Surgical Technologies, Inc. | Attachment device and methods of using the same |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7871435B2 (en) | 2004-01-23 | 2011-01-18 | Edwards Lifesciences Corporation | Anatomically approximate prosthetic mitral heart valve |
US7976539B2 (en) * | 2004-03-05 | 2011-07-12 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
US20050228494A1 (en) * | 2004-03-29 | 2005-10-13 | Salvador Marquez | Controlled separation heart valve frame |
US8216299B2 (en) * | 2004-04-01 | 2012-07-10 | Cook Medical Technologies Llc | Method to retract a body vessel wall with remodelable material |
US7637937B2 (en) * | 2004-04-08 | 2009-12-29 | Cook Incorporated | Implantable medical device with optimized shape |
US20090030435A1 (en) * | 2004-09-27 | 2009-01-29 | Theranova, Llc | Method and apparatus for anchoring cardiovascular implants |
US7850704B2 (en) * | 2004-09-27 | 2010-12-14 | Theranova, Llc | Method and apparatus for anchoring implants |
US7989157B2 (en) * | 2005-01-11 | 2011-08-02 | Medtronic, Inc. | Solution for storing bioprosthetic tissue used in a biological prosthesis |
US8574257B2 (en) * | 2005-02-10 | 2013-11-05 | Edwards Lifesciences Corporation | System, device, and method for providing access in a cardiovascular environment |
US7513909B2 (en) * | 2005-04-08 | 2009-04-07 | Arbor Surgical Technologies, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US7722666B2 (en) * | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
CN101180010B (en) * | 2005-05-24 | 2010-12-01 | 爱德华兹生命科学公司 | Rapid deployment prosthetic heart valve |
EP1895942B1 (en) * | 2005-05-27 | 2020-05-13 | Medtronic, Inc. | Gasket with collar for prosthetic heart valves |
US7238200B2 (en) * | 2005-06-03 | 2007-07-03 | Arbor Surgical Technologies, Inc. | Apparatus and methods for making leaflets and valve prostheses including such leaflets |
US7780723B2 (en) | 2005-06-13 | 2010-08-24 | Edwards Lifesciences Corporation | Heart valve delivery system |
US7776084B2 (en) | 2005-07-13 | 2010-08-17 | Edwards Lifesciences Corporation | Prosthetic mitral heart valve having a contoured sewing ring |
US7632308B2 (en) * | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
GB0524087D0 (en) * | 2005-11-25 | 2006-01-04 | Symetis Ag | Biodegradable scaffold |
US20070168022A1 (en) * | 2006-01-17 | 2007-07-19 | Eldridge Charles J | Heart valve |
US7967857B2 (en) | 2006-01-27 | 2011-06-28 | Medtronic, Inc. | Gasket with spring collar for prosthetic heart valves and methods for making and using them |
WO2007106755A1 (en) * | 2006-03-10 | 2007-09-20 | Arbor Surgical Technologies, Inc. | Valve introducers and methods for making and using them |
EP2004095B1 (en) | 2006-03-28 | 2019-06-12 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
EP2023860A2 (en) * | 2006-04-29 | 2009-02-18 | Arbor Surgical Technologies, Inc. | Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them |
US8021161B2 (en) * | 2006-05-01 | 2011-09-20 | Edwards Lifesciences Corporation | Simulated heart valve root for training and testing |
US9408607B2 (en) | 2009-07-02 | 2016-08-09 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
US9585743B2 (en) | 2006-07-31 | 2017-03-07 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
AU2007281553B2 (en) | 2006-07-31 | 2013-09-19 | Edwards Lifesciences Cardiaq Llc | Sealable endovascular implants and methods for their use |
US8918193B2 (en) * | 2006-08-16 | 2014-12-23 | Vahe S. Yacoubian | Heart wire |
CN103933612B (en) | 2006-10-27 | 2016-06-22 | 爱德华兹生命科学公司 | Biological tissue for Srgery grafting |
US8236045B2 (en) | 2006-12-22 | 2012-08-07 | Edwards Lifesciences Corporation | Implantable prosthetic valve assembly and method of making the same |
US9101691B2 (en) | 2007-06-11 | 2015-08-11 | Edwards Lifesciences Corporation | Methods for pre-stressing and capping bioprosthetic tissue |
US9566178B2 (en) | 2010-06-24 | 2017-02-14 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
WO2009023818A1 (en) * | 2007-08-15 | 2009-02-19 | Theranova, Llc | Method and apparatus for automated active sterilization of fully implanted devices |
DE102007043830A1 (en) | 2007-09-13 | 2009-04-02 | Lozonschi, Lucian, Madison | Heart valve stent |
AU2008305600B2 (en) | 2007-09-26 | 2013-07-04 | St. Jude Medical, Inc. | Collapsible prosthetic heart valves |
US9532868B2 (en) | 2007-09-28 | 2017-01-03 | St. Jude Medical, Inc. | Collapsible-expandable prosthetic heart valves with structures for clamping native tissue |
WO2009045331A1 (en) | 2007-09-28 | 2009-04-09 | St. Jude Medical, Inc. | Two-stage collapsible/expandable prosthetic heart valves and anchoring systems |
CA2702672C (en) * | 2007-10-15 | 2016-03-15 | Edwards Lifesciences Corporation | Transcatheter heart valve with micro-anchors |
US7846199B2 (en) * | 2007-11-19 | 2010-12-07 | Cook Incorporated | Remodelable prosthetic valve |
EP2231070B1 (en) | 2007-12-14 | 2013-05-22 | Edwards Lifesciences Corporation | Leaflet attachment frame for a prosthetic valve |
US8357387B2 (en) | 2007-12-21 | 2013-01-22 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
CN101959478B (en) | 2008-02-29 | 2013-12-18 | 爱德华兹生命科学公司 | Expandable member for deploying prosthetic device |
US9241792B2 (en) | 2008-02-29 | 2016-01-26 | Edwards Lifesciences Corporation | Two-step heart valve implantation |
US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
PT3653173T (en) | 2008-06-06 | 2021-07-12 | Edwards Lifesciences Corp | Low profile transcatheter heart valve |
US8323335B2 (en) | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
EP3756622A1 (en) | 2008-07-15 | 2020-12-30 | St. Jude Medical, LLC | Collapsible and re-expandable prosthetic heart valve cuff designs and complementary technological applications |
US9603558B2 (en) | 2008-08-15 | 2017-03-28 | Theranova, Llc | Methods and devices for the diagnosis and treatment of diabetes |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US8790387B2 (en) | 2008-10-10 | 2014-07-29 | Edwards Lifesciences Corporation | Expandable sheath for introducing an endovascular delivery device into a body |
US8690936B2 (en) | 2008-10-10 | 2014-04-08 | Edwards Lifesciences Corporation | Expandable sheath for introducing an endovascular delivery device into a body |
US8449625B2 (en) | 2009-10-27 | 2013-05-28 | Edwards Lifesciences Corporation | Methods of measuring heart valve annuluses for valve replacement |
WO2010065265A2 (en) | 2008-11-25 | 2010-06-10 | Edwards Lifesciences Corporation | Apparatus and method for in situ expansion of prosthetic device |
US8308798B2 (en) | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
US20110011917A1 (en) * | 2008-12-31 | 2011-01-20 | Hansen Medical, Inc. | Methods, devices, and kits for treating valve prolapse |
US9980818B2 (en) | 2009-03-31 | 2018-05-29 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
US8348998B2 (en) | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
GR1007028B (en) * | 2009-11-11 | 2010-10-22 | Ευσταθιος-Ανδρεας Αγαθος | SUPPORT OF BIO-ADDITIONAL VALVES WITH DIAGNOSTIC HEART SHAPE |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
EP3649985B8 (en) | 2009-12-08 | 2021-04-21 | Avalon Medical Ltd. | Device and system for transcatheter mitral valve replacement |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US8795354B2 (en) | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
BR122014006918B1 (en) | 2010-03-23 | 2020-09-29 | Edwards Lifesciences Corporation. | METHOD FOR PREPARING BIOPROTETIC TISSUE MEMBRANE MATERIAL |
EP2568924B1 (en) | 2010-05-10 | 2021-01-13 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US9554901B2 (en) | 2010-05-12 | 2017-01-31 | Edwards Lifesciences Corporation | Low gradient prosthetic heart valve |
EP2585157B1 (en) | 2010-06-28 | 2019-10-16 | Colibri Heart Valve LLC | Method and apparatus for the endoluminal delivery of intravascular devices |
EP4241701B1 (en) | 2010-07-09 | 2024-09-18 | Highlife SAS | Transcatheter atrio-ventricular valve prosthesis |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
EP4098227A1 (en) | 2010-07-23 | 2022-12-07 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
US8641757B2 (en) | 2010-09-10 | 2014-02-04 | Edwards Lifesciences Corporation | Systems for rapidly deploying surgical heart valves |
US9125741B2 (en) | 2010-09-10 | 2015-09-08 | Edwards Lifesciences Corporation | Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves |
US9370418B2 (en) | 2010-09-10 | 2016-06-21 | Edwards Lifesciences Corporation | Rapidly deployable surgical heart valves |
US8845720B2 (en) | 2010-09-27 | 2014-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve frame with flexible commissures |
CN105380730B (en) | 2010-10-05 | 2018-08-17 | 爱德华兹生命科学公司 | Heart valve prosthesis |
DE202011111128U1 (en) | 2010-10-05 | 2020-05-27 | Edwards Lifesciences Corporation | Prosthetic heart valve |
CA3027755C (en) | 2010-12-14 | 2021-05-11 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets |
GB2488530A (en) * | 2011-02-18 | 2012-09-05 | David J Wheatley | Heart valve |
US9155619B2 (en) | 2011-02-25 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US8945209B2 (en) | 2011-05-20 | 2015-02-03 | Edwards Lifesciences Corporation | Encapsulated heart valve |
US9289282B2 (en) | 2011-05-31 | 2016-03-22 | Edwards Lifesciences Corporation | System and method for treating valve insufficiency or vessel dilatation |
US9358107B2 (en) * | 2011-06-30 | 2016-06-07 | Edwards Lifesciences Corporation | Systems, dies, and methods for processing pericardial tissue |
US8795357B2 (en) | 2011-07-15 | 2014-08-05 | Edwards Lifesciences Corporation | Perivalvular sealing for transcatheter heart valve |
EP2734153A2 (en) | 2011-07-20 | 2014-05-28 | Boston Scientific Scimed, Inc. | Heart valve replacement |
US9119716B2 (en) | 2011-07-27 | 2015-09-01 | Edwards Lifesciences Corporation | Delivery systems for prosthetic heart valve |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2013021375A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Percutaneous mitral valve replacement and sealing |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
EP2741711B1 (en) | 2011-08-11 | 2018-05-30 | Tendyne Holdings, Inc. | Improvements for prosthetic valves and related inventions |
US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
EP4049626A1 (en) | 2011-12-09 | 2022-08-31 | Edwards Lifesciences Corporation | Prosthetic heart valve having improved commissure supports |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
EP2816980B1 (en) | 2012-02-22 | 2018-07-25 | Syntheon TAVR, LLC | Actively controllable stent, stent graft and heart valve |
WO2014022124A1 (en) | 2012-07-28 | 2014-02-06 | Tendyne Holdings, Inc. | Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
US9675454B2 (en) | 2012-07-30 | 2017-06-13 | Tendyne Holdings, Inc. | Delivery systems and methods for transcatheter prosthetic valves |
US20140067048A1 (en) | 2012-09-06 | 2014-03-06 | Edwards Lifesciences Corporation | Heart Valve Sealing Devices |
US10543088B2 (en) | 2012-09-14 | 2020-01-28 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US10849755B2 (en) | 2012-09-14 | 2020-12-01 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US9750595B2 (en) | 2012-09-28 | 2017-09-05 | Covidien Lp | Implantable medical devices which include grip-members and methods of use thereof |
US10238771B2 (en) | 2012-11-08 | 2019-03-26 | Edwards Lifesciences Corporation | Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system |
US8628571B1 (en) | 2012-11-13 | 2014-01-14 | Mitraltech Ltd. | Percutaneously-deliverable mechanical valve |
EP2922592B1 (en) | 2012-11-21 | 2022-09-21 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic heart valves |
US10966820B2 (en) | 2012-12-19 | 2021-04-06 | W. L. Gore & Associates, Inc. | Geometric control of bending character in prosthetic heart valve leaflets |
US10039638B2 (en) | 2012-12-19 | 2018-08-07 | W. L. Gore & Associates, Inc. | Geometric prosthetic heart valves |
US9737398B2 (en) | 2012-12-19 | 2017-08-22 | W. L. Gore & Associates, Inc. | Prosthetic valves, frames and leaflets and methods thereof |
EP4166111A1 (en) | 2013-01-24 | 2023-04-19 | Cardiovalve Ltd. | Ventricularly-anchored prosthetic valves |
US9439763B2 (en) | 2013-02-04 | 2016-09-13 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
US9168129B2 (en) | 2013-02-12 | 2015-10-27 | Edwards Lifesciences Corporation | Artificial heart valve with scalloped frame design |
US11007058B2 (en) | 2013-03-15 | 2021-05-18 | Edwards Lifesciences Corporation | Valved aortic conduits |
CA2900367C (en) | 2013-03-15 | 2020-12-22 | Edwards Lifesciences Corporation | Valved aortic conduits |
US9486306B2 (en) | 2013-04-02 | 2016-11-08 | Tendyne Holdings, Inc. | Inflatable annular sealing device for prosthetic mitral valve |
US10463489B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US11224510B2 (en) | 2013-04-02 | 2022-01-18 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10478293B2 (en) | 2013-04-04 | 2019-11-19 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
CA3219973A1 (en) | 2013-05-20 | 2014-11-27 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US9610159B2 (en) | 2013-05-30 | 2017-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
US9468527B2 (en) | 2013-06-12 | 2016-10-18 | Edwards Lifesciences Corporation | Cardiac implant with integrated suture fasteners |
EP3013281B1 (en) | 2013-06-25 | 2018-08-15 | Tendyne Holdings, Inc. | Thrombus management and structural compliance features for prosthetic heart valves |
EP3027144B1 (en) | 2013-08-01 | 2017-11-08 | Tendyne Holdings, Inc. | Epicardial anchor devices |
US9919137B2 (en) | 2013-08-28 | 2018-03-20 | Edwards Lifesciences Corporation | Integrated balloon catheter inflation system |
EP3046512B1 (en) | 2013-09-20 | 2024-03-06 | Edwards Lifesciences Corporation | Heart valves with increased effective orifice area |
US9615922B2 (en) | 2013-09-30 | 2017-04-11 | Edwards Lifesciences Corporation | Method and apparatus for preparing a contoured biological tissue |
US10959839B2 (en) | 2013-10-08 | 2021-03-30 | Edwards Lifesciences Corporation | Method for directing cellular migration patterns on a biological tissue |
WO2015058039A1 (en) | 2013-10-17 | 2015-04-23 | Robert Vidlund | Apparatus and methods for alignment and deployment of intracardiac devices |
JP6554094B2 (en) | 2013-10-28 | 2019-07-31 | テンダイン ホールディングス,インコーポレイテッド | Prosthetic heart valve and system and method for delivering an artificial heart valve |
US9526611B2 (en) | 2013-10-29 | 2016-12-27 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
US9913715B2 (en) | 2013-11-06 | 2018-03-13 | St. Jude Medical, Cardiology Division, Inc. | Paravalvular leak sealing mechanism |
US20150122687A1 (en) | 2013-11-06 | 2015-05-07 | Edwards Lifesciences Corporation | Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage |
CR20160240A (en) | 2013-11-11 | 2016-08-04 | Edwards Lifesciences Cardiaq Llc | SYSTEMS AND METHODS FOR THE MANUFACTURE OF THE FRAME OF A CANNULA |
US9622863B2 (en) | 2013-11-22 | 2017-04-18 | Edwards Lifesciences Corporation | Aortic insufficiency repair device and method |
US10098734B2 (en) | 2013-12-05 | 2018-10-16 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US9504565B2 (en) | 2013-12-06 | 2016-11-29 | W. L. Gore & Associates, Inc. | Asymmetric opening and closing prosthetic valve leaflet |
WO2015120122A2 (en) | 2014-02-05 | 2015-08-13 | Robert Vidlund | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US9986993B2 (en) | 2014-02-11 | 2018-06-05 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
CN110338911B (en) | 2014-03-10 | 2022-12-23 | 坦迪尼控股股份有限公司 | Apparatus and method for positioning and monitoring tether load of prosthetic mitral valve |
US9549816B2 (en) | 2014-04-03 | 2017-01-24 | Edwards Lifesciences Corporation | Method for manufacturing high durability heart valve |
US9585752B2 (en) | 2014-04-30 | 2017-03-07 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
AU2015256601B2 (en) | 2014-05-09 | 2020-01-23 | Foldax, Inc. | Replacement heart valves and their methods of use and manufacture |
US9532870B2 (en) | 2014-06-06 | 2017-01-03 | Edwards Lifesciences Corporation | Prosthetic valve for replacing a mitral valve |
USD867594S1 (en) | 2015-06-19 | 2019-11-19 | Edwards Lifesciences Corporation | Prosthetic heart valve |
CA2914094C (en) | 2014-06-20 | 2021-01-05 | Edwards Lifesciences Corporation | Surgical heart valves identifiable post-implant |
US10195026B2 (en) | 2014-07-22 | 2019-02-05 | Edwards Lifesciences Corporation | Mitral valve anchoring |
EP4066786A1 (en) | 2014-07-30 | 2022-10-05 | Cardiovalve Ltd. | Articulatable prosthetic valve |
EP3182929B1 (en) | 2014-08-18 | 2023-08-09 | Edwards Lifesciences Corporation | Frame with integral sewing cuff for prosthetic valves |
US10058424B2 (en) | 2014-08-21 | 2018-08-28 | Edwards Lifesciences Corporation | Dual-flange prosthetic valve frame |
US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
EP3242630A2 (en) | 2015-01-07 | 2017-11-15 | Tendyne Holdings, Inc. | Prosthetic mitral valves and apparatus and methods for delivery of same |
EP3884906A1 (en) | 2015-02-05 | 2021-09-29 | Tendyne Holdings, Inc. | Expandable epicardial pads and devices and methods for delivery of same |
EP3253333B1 (en) | 2015-02-05 | 2024-04-03 | Cardiovalve Ltd | Prosthetic valve with axially-sliding frames |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
EP3256077B1 (en) | 2015-02-13 | 2024-03-27 | Boston Scientific Scimed, Inc. | Valve replacement using rotational anchors |
US10327896B2 (en) | 2015-04-10 | 2019-06-25 | Edwards Lifesciences Corporation | Expandable sheath with elastomeric cross sectional portions |
US10792471B2 (en) | 2015-04-10 | 2020-10-06 | Edwards Lifesciences Corporation | Expandable sheath |
EP3283010B1 (en) | 2015-04-16 | 2020-06-17 | Tendyne Holdings, Inc. | Apparatus for delivery and repositioning of transcatheter prosthetic valves |
US10064718B2 (en) | 2015-04-16 | 2018-09-04 | Edwards Lifesciences Corporation | Low-profile prosthetic heart valve for replacing a mitral valve |
US10010417B2 (en) | 2015-04-16 | 2018-07-03 | Edwards Lifesciences Corporation | Low-profile prosthetic heart valve for replacing a mitral valve |
CR20170577A (en) | 2015-07-02 | 2019-05-03 | Edwards Lifesciences Corp | Hybrid heart valves adapted for post-implant expansion.- |
WO2017004374A1 (en) | 2015-07-02 | 2017-01-05 | Edwards Lifesciences Corporation | Integrated hybrid heart valves |
EP3344158B1 (en) | 2015-09-02 | 2023-03-01 | Edwards Lifesciences Corporation | Spacer for securing a transcatheter valve to a bioprosthetic cardiac structure |
US10080653B2 (en) | 2015-09-10 | 2018-09-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
US10327894B2 (en) | 2015-09-18 | 2019-06-25 | Tendyne Holdings, Inc. | Methods for delivery of prosthetic mitral valves |
US10335275B2 (en) | 2015-09-29 | 2019-07-02 | Millipede, Inc. | Methods for delivery of heart valve devices using intravascular ultrasound imaging |
US10470876B2 (en) | 2015-11-10 | 2019-11-12 | Edwards Lifesciences Corporation | Transcatheter heart valve for replacing natural mitral valve |
US10376364B2 (en) | 2015-11-10 | 2019-08-13 | Edwards Lifesciences Corporation | Implant delivery capsule |
US10555813B2 (en) | 2015-11-17 | 2020-02-11 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
AU2016362474B2 (en) | 2015-12-03 | 2021-04-22 | Tendyne Holdings, Inc. | Frame features for prosthetic mitral valves |
EP3397206B1 (en) | 2015-12-28 | 2022-06-08 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
US10179043B2 (en) | 2016-02-12 | 2019-01-15 | Edwards Lifesciences Corporation | Prosthetic heart valve having multi-level sealing member |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US10667904B2 (en) | 2016-03-08 | 2020-06-02 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
CN108882980B (en) | 2016-03-24 | 2020-12-08 | 爱德华兹生命科学公司 | Delivery system for prosthetic heart valves |
US10470877B2 (en) | 2016-05-03 | 2019-11-12 | Tendyne Holdings, Inc. | Apparatus and methods for anterior valve leaflet management |
US10456245B2 (en) | 2016-05-16 | 2019-10-29 | Edwards Lifesciences Corporation | System and method for applying material to a stent |
EP3468480B1 (en) | 2016-06-13 | 2023-01-11 | Tendyne Holdings, Inc. | Sequential delivery of two-part prosthetic mitral valve |
EP3478224B1 (en) | 2016-06-30 | 2022-11-02 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus for delivery of same |
US11065116B2 (en) | 2016-07-12 | 2021-07-20 | Tendyne Holdings, Inc. | Apparatus and methods for trans-septal retrieval of prosthetic heart valves |
US11096781B2 (en) | 2016-08-01 | 2021-08-24 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US20190231525A1 (en) | 2016-08-01 | 2019-08-01 | Mitraltech Ltd. | Minimally-invasive delivery systems |
CA3031187A1 (en) | 2016-08-10 | 2018-02-15 | Cardiovalve Ltd. | Prosthetic valve with concentric frames |
EP3531978A4 (en) | 2016-10-28 | 2020-06-03 | Foldax, Inc. | Prosthetic heart valves with elastic support structures and related methods |
US10973631B2 (en) | 2016-11-17 | 2021-04-13 | Edwards Lifesciences Corporation | Crimping accessory device for a prosthetic valve |
US10463484B2 (en) | 2016-11-17 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic heart valve having leaflet inflow below frame |
US10603165B2 (en) | 2016-12-06 | 2020-03-31 | Edwards Lifesciences Corporation | Mechanically expanding heart valve and delivery apparatus therefor |
USD846122S1 (en) | 2016-12-16 | 2019-04-16 | Edwards Lifesciences Corporation | Heart valve sizer |
US11013600B2 (en) | 2017-01-23 | 2021-05-25 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11654023B2 (en) | 2017-01-23 | 2023-05-23 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
CA3051272C (en) * | 2017-01-23 | 2023-08-22 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US11185406B2 (en) | 2017-01-23 | 2021-11-30 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
EP3579789A4 (en) | 2017-02-10 | 2020-09-30 | Millipede, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US10463485B2 (en) | 2017-04-06 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic valve holders with automatic deploying mechanisms |
EP3614969B1 (en) | 2017-04-28 | 2023-05-03 | Edwards Lifesciences Corporation | Prosthetic heart valve with collapsible holder |
US11135056B2 (en) | 2017-05-15 | 2021-10-05 | Edwards Lifesciences Corporation | Devices and methods of commissure formation for prosthetic heart valve |
EP4427706A2 (en) | 2017-05-22 | 2024-09-11 | Edwards Lifesciences Corporation | Valve anchor and installation method |
WO2018222434A1 (en) | 2017-05-31 | 2018-12-06 | Edwards Lifesciences Corporation | Collagen fibers and articles formed therefrom |
US12064341B2 (en) | 2017-05-31 | 2024-08-20 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US11026785B2 (en) | 2017-06-05 | 2021-06-08 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
US10869759B2 (en) | 2017-06-05 | 2020-12-22 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
EP3641700A4 (en) | 2017-06-21 | 2020-08-05 | Edwards Lifesciences Corporation | Dual-wireform limited expansion heart valves |
EP3651695B1 (en) | 2017-07-13 | 2023-04-19 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus for delivery of same |
US10918473B2 (en) | 2017-07-18 | 2021-02-16 | Edwards Lifesciences Corporation | Transcatheter heart valve storage container and crimping mechanism |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US12064347B2 (en) | 2017-08-03 | 2024-08-20 | Cardiovalve Ltd. | Prosthetic heart valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
JP7297735B2 (en) | 2017-08-11 | 2023-06-26 | エドワーズ ライフサイエンシーズ コーポレイション | Sealing elements for prosthetic heart valves |
US11083575B2 (en) | 2017-08-14 | 2021-08-10 | Edwards Lifesciences Corporation | Heart valve frame design with non-uniform struts |
US10932903B2 (en) | 2017-08-15 | 2021-03-02 | Edwards Lifesciences Corporation | Skirt assembly for implantable prosthetic valve |
US10898319B2 (en) | 2017-08-17 | 2021-01-26 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10973628B2 (en) | 2017-08-18 | 2021-04-13 | Edwards Lifesciences Corporation | Pericardial sealing member for prosthetic heart valve |
US10722353B2 (en) | 2017-08-21 | 2020-07-28 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
CN111031967B (en) | 2017-08-28 | 2022-08-09 | 坦迪尼控股股份有限公司 | Prosthetic heart valve with tether connection features |
US10973629B2 (en) | 2017-09-06 | 2021-04-13 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US11147667B2 (en) | 2017-09-08 | 2021-10-19 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
WO2019051476A1 (en) | 2017-09-11 | 2019-03-14 | Incubar, LLC | Conduit vascular implant sealing device for reducing endoleak |
US11123183B2 (en) | 2017-10-31 | 2021-09-21 | W. L. Gore & Associates, Inc. | Prosthetic heart valve |
EP3703615B1 (en) | 2017-10-31 | 2024-05-15 | W. L. Gore & Associates, Inc. | Transcatheter deployment systems and associated methods |
CA3083533A1 (en) | 2017-12-11 | 2019-06-20 | California Institute Of Technology | Systems, devices, and methods relating to the manufacture of intravascularly implantable prosthetic valves |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
WO2019147585A1 (en) | 2018-01-23 | 2019-08-01 | Edwards Lifesciences Corporation | Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby |
US11337805B2 (en) | 2018-01-23 | 2022-05-24 | Edwards Lifesciences Corporation | Prosthetic valve holders, systems, and methods |
US11318011B2 (en) | 2018-04-27 | 2022-05-03 | Edwards Lifesciences Corporation | Mechanically expandable heart valve with leaflet clamps |
USD908874S1 (en) | 2018-07-11 | 2021-01-26 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
CN214511420U (en) | 2018-10-19 | 2021-10-29 | 爱德华兹生命科学公司 | Implantable prosthetic device, medical device assembly, and delivery assembly |
WO2020092205A1 (en) | 2018-11-01 | 2020-05-07 | Edwards Lifesciences Corporation | Transcatheter pulmonic regenerative valve |
USD926322S1 (en) | 2018-11-07 | 2021-07-27 | W. L. Gore & Associates, Inc. | Heart valve cover |
CN113507902B (en) | 2019-01-17 | 2024-08-09 | 爱德华兹生命科学公司 | Frame for prosthetic heart valve |
WO2020198273A2 (en) * | 2019-03-26 | 2020-10-01 | Edwards Lifesciences Corporation | Prosthetic heart valve |
EP3831343B1 (en) | 2019-12-05 | 2024-01-31 | Tendyne Holdings, Inc. | Braided anchor for mitral valve |
WO2021126778A1 (en) | 2019-12-16 | 2021-06-24 | Edwards Lifesciences Corporation | Valve holder assembly with suture looping protection |
US11648114B2 (en) | 2019-12-20 | 2023-05-16 | Tendyne Holdings, Inc. | Distally loaded sheath and loading funnel |
EP4087501A4 (en) * | 2020-02-18 | 2024-01-24 | LSI Solutions, Inc. | Cardiac repair structure, apparatus, and methods thereof |
US11951002B2 (en) | 2020-03-30 | 2024-04-09 | Tendyne Holdings, Inc. | Apparatus and methods for valve and tether fixation |
WO2021257774A1 (en) | 2020-06-18 | 2021-12-23 | Edwards Lifesciences Corporation | Crimping methods |
EP4199860A1 (en) | 2020-08-19 | 2023-06-28 | Tendyne Holdings, Inc. | Fully-transseptal apical pad with pulley for tensioning |
CN116981432A (en) | 2021-01-20 | 2023-10-31 | 爱德华兹生命科学公司 | Connection skirt for attaching leaflets to a frame of a prosthetic heart valve |
IL305529A (en) | 2021-03-23 | 2023-10-01 | Edwards Lifesciences Corp | Prosthetic heart valve having elongated sealing member |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2822819A (en) | 1953-08-07 | 1958-02-11 | Geeraert Corp | Cuspate check valve |
US3548418A (en) | 1968-05-03 | 1970-12-22 | Cutter Lab | Graft valve transplantation for human hearts and graft-support ring therefor |
US3570014A (en) | 1968-09-16 | 1971-03-16 | Warren D Hancock | Stent for heart valve |
US3714671A (en) | 1970-11-30 | 1973-02-06 | Cutter Lab | Tissue-type heart valve with a graft support ring or stent |
US3755823A (en) | 1971-04-23 | 1973-09-04 | Hancock Laboratories Inc | Flexible stent for heart valve |
US3744062A (en) | 1971-10-08 | 1973-07-10 | V Parsonnet | Heart valve construction having a collagen cover encapsulation thereon |
US4291420A (en) | 1973-11-09 | 1981-09-29 | Medac Gesellschaft Fur Klinische Spezialpraparate Mbh | Artificial heart valve |
US3983581A (en) | 1975-01-20 | 1976-10-05 | William W. Angell | Heart valve stent |
US4192020A (en) | 1975-05-07 | 1980-03-11 | Washington University | Heart valve prosthesis |
US4035849A (en) | 1975-11-17 | 1977-07-19 | William W. Angell | Heart valve stent and process for preparing a stented heart valve prosthesis |
AR206762A1 (en) | 1976-01-01 | 1976-08-13 | Pisanu A | LOW PROFILE BIOPROTHESIS DERIVED FROM PORCINE HETEROLOGICAL AORTIC VALVE |
CA1069652A (en) | 1976-01-09 | 1980-01-15 | Alain F. Carpentier | Supported bioprosthetic heart valve with compliant orifice ring |
US4084268A (en) | 1976-04-22 | 1978-04-18 | Shiley Laboratories, Incorporated | Prosthetic tissue heart valve |
US4297749A (en) | 1977-04-25 | 1981-11-03 | Albany International Corp. | Heart valve prosthesis |
US4172295A (en) | 1978-01-27 | 1979-10-30 | Shiley Scientific, Inc. | Tri-cuspid three-tissue prosthetic heart valve |
US4247292A (en) | 1979-06-06 | 1981-01-27 | Angell William W | Natural tissue heart valve fixation process |
US4388735A (en) | 1980-11-03 | 1983-06-21 | Shiley Inc. | Low profile prosthetic xenograft heart valve |
EP0125393B1 (en) * | 1980-11-03 | 1987-12-09 | Shiley Incorporated | Prosthetic heart valve |
US4470157A (en) | 1981-04-27 | 1984-09-11 | Love Jack W | Tricuspid prosthetic tissue heart valve |
US4501030A (en) | 1981-08-17 | 1985-02-26 | American Hospital Supply Corporation | Method of leaflet attachment for prosthetic heart valves |
ATE21330T1 (en) | 1982-01-20 | 1986-08-15 | Martin Morris Black | ARTIFICIAL HEART VALVES. |
US4458570A (en) * | 1982-01-25 | 1984-07-10 | Marvin Glass & Associates | Sheet material dispenser |
GB8300636D0 (en) | 1983-01-11 | 1983-02-09 | Black M M | Heart valve replacements |
GB8424582D0 (en) | 1984-09-28 | 1984-11-07 | Univ Glasgow | Heart valve prosthesis |
CH672247A5 (en) | 1986-03-06 | 1989-11-15 | Mo Vysshee Tekhnicheskoe Uchil | |
US4725274A (en) | 1986-10-24 | 1988-02-16 | Baxter Travenol Laboratories, Inc. | Prosthetic heart valve |
US4851000A (en) | 1987-07-31 | 1989-07-25 | Pacific Biomedical Holdings, Ltd. | Bioprosthetic valve stent |
US5147391A (en) | 1990-04-11 | 1992-09-15 | Carbomedics, Inc. | Bioprosthetic heart valve with semi-permeable commissure posts and deformable leaflets |
US5037434A (en) | 1990-04-11 | 1991-08-06 | Carbomedics, Inc. | Bioprosthetic heart valve with elastic commissures |
US5163955A (en) | 1991-01-24 | 1992-11-17 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
US5755782A (en) | 1991-01-24 | 1998-05-26 | Autogenics | Stents for autologous tissue heart valve |
US5489298A (en) | 1991-01-24 | 1996-02-06 | Autogenics | Rapid assembly concentric mating stent, tissue heart valve with enhanced clamping and tissue exposure |
US5161955A (en) | 1991-08-20 | 1992-11-10 | Danielson Associates, Inc. | High vacuum pump using bulk getter material |
AU5014893A (en) | 1992-08-13 | 1994-03-15 | Autogenics | Tissue heart valve with concentric mating stents |
GB9312666D0 (en) * | 1993-06-18 | 1993-08-04 | Vesely Ivan | Bioprostetic heart valve |
US5554673A (en) * | 1993-11-29 | 1996-09-10 | Polygenex International, Inc. | Dip molded polyurethane film compositions |
US5425741A (en) | 1993-12-17 | 1995-06-20 | Autogenics | Tissue cutting die |
US5595571A (en) * | 1994-04-18 | 1997-01-21 | Hancock Jaffe Laboratories | Biological material pre-fixation treatment |
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
EP1014895B1 (en) * | 1996-12-10 | 2006-03-08 | Purdue Research Foundation | Artificial vascular valves |
US5928281A (en) * | 1997-03-27 | 1999-07-27 | Baxter International Inc. | Tissue heart valves |
US5935163A (en) * | 1998-03-31 | 1999-08-10 | Shelhigh, Inc. | Natural tissue heart valve prosthesis |
US6095968A (en) * | 1998-04-10 | 2000-08-01 | Cardio Technologies, Inc. | Reinforcement device |
US6254636B1 (en) * | 1998-06-26 | 2001-07-03 | St. Jude Medical, Inc. | Single suture biological tissue aortic stentless valve |
-
1998
- 1998-09-28 US US09/161,809 patent/US6334873B1/en not_active Expired - Lifetime
-
1999
- 1999-09-22 JP JP2000571856A patent/JP2002525169A/en active Pending
- 1999-09-22 WO PCT/US1999/021997 patent/WO2000018333A1/en not_active Application Discontinuation
- 1999-09-22 EP EP99949797A patent/EP1117354A1/en not_active Withdrawn
- 1999-09-22 CN CN99811423A patent/CN1328436A/en active Pending
- 1999-09-22 AU AU62594/99A patent/AU6259499A/en not_active Abandoned
-
2001
- 2001-10-16 US US09/982,609 patent/US20020026238A1/en not_active Abandoned
Cited By (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7896913B2 (en) | 2000-02-28 | 2011-03-01 | Jenavalve Technology, Inc. | Anchoring system for implantable heart valve prostheses |
USRE45130E1 (en) | 2000-02-28 | 2014-09-09 | Jenavalve Technology Gmbh | Device for fastening and anchoring cardiac valve prostheses |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US9192471B2 (en) | 2007-01-08 | 2015-11-24 | Millipede, Inc. | Device for translumenal reshaping of a mitral valve annulus |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
JP2010524632A (en) * | 2007-04-26 | 2010-07-22 | セント ジュード メディカル インコーポレイテッド | Technique for attaching a flexible leaflet of a prosthetic heart valve to a support structure |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11154398B2 (en) | 2008-02-26 | 2021-10-26 | JenaValve Technology. Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
JP2012521222A (en) * | 2009-03-19 | 2012-09-13 | ミリピード リミテッド ライアビリティー カンパニー | Reconstruction of cardiac features |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US9795480B2 (en) | 2010-08-24 | 2017-10-24 | Millipede, Inc. | Reconfiguring tissue features of a heart annulus |
US9510947B2 (en) | 2011-10-21 | 2016-12-06 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient |
US9878127B2 (en) | 2012-05-16 | 2018-01-30 | Jenavalve Technology, Inc. | Catheter delivery system for heart valve prosthesis |
US11950999B2 (en) | 2012-07-25 | 2024-04-09 | Edwards Lifesciences Corporation | Everting transcatheter valve and methods |
US12115063B2 (en) | 2012-07-27 | 2024-10-15 | Edwards Lifesciences Corporation | Multi-frame prosthetic valve apparatus and methods |
US11896481B2 (en) | 2012-12-19 | 2024-02-13 | Edwards Lifesciences Corporation | Truncated leaflet for prosthetic heart valves |
US11826248B2 (en) | 2012-12-19 | 2023-11-28 | Edwards Lifesciences Corporation | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US11872122B2 (en) | 2012-12-19 | 2024-01-16 | Edwards Lifesciences Corporation | Methods for improved prosthetic heart valve with leaflet shelving |
US10433954B2 (en) | 2013-08-30 | 2019-10-08 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US9867694B2 (en) | 2013-08-30 | 2018-01-16 | Jenavalve Technology Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US9180005B1 (en) | 2014-07-17 | 2015-11-10 | Millipede, Inc. | Adjustable endolumenal mitral valve ring |
US12023235B2 (en) | 2014-07-17 | 2024-07-02 | Boston Scientific Scimed, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US11471276B2 (en) | 2014-09-15 | 2022-10-18 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
JP7225189B2 (en) | 2014-12-18 | 2023-02-20 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | Prosthetic valve with mechanically coupled leaflets |
JP2019069166A (en) * | 2014-12-18 | 2019-05-09 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Prosthetic valve with mechanically coupled leaflet |
JP2021037378A (en) * | 2014-12-18 | 2021-03-11 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Prosthetic valves with mechanically coupled leaflets |
JP2017538518A (en) * | 2014-12-18 | 2017-12-28 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Prosthetic valve with mechanically coupled leaflets |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US12121461B2 (en) | 2016-03-17 | 2024-10-22 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US12059344B2 (en) | 2017-09-12 | 2024-08-13 | Edwards Lifesciences Corporation | Leaflet frame attachment for prosthetic valves |
US11857412B2 (en) | 2017-09-27 | 2024-01-02 | Edwards Lifesciences Corporation | Prosthetic valve with expandable frame and associated systems and methods |
US11986387B2 (en) | 2017-09-27 | 2024-05-21 | Edwards Lifesciences Corporation | Prosthetic valves with mechanically coupled leaflets |
US12064344B2 (en) | 2017-10-13 | 2024-08-20 | Edwards Lifesciences Corporation | Telescoping prosthetic valve and delivery system |
US11439502B2 (en) | 2017-10-31 | 2022-09-13 | W. L. Gore & Associates, Inc. | Medical valve and leaflet promoting tissue ingrowth |
US12053374B2 (en) | 2017-10-31 | 2024-08-06 | Edwards Lifesciences Corporation | Medical valve and leaflet promoting tissue ingrowth |
US11974916B2 (en) | 2017-10-31 | 2024-05-07 | Edwards Lifesciences Corporation | Jacket for surgical heart valve |
JP2021500977A (en) * | 2017-10-31 | 2021-01-14 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Surgical heart valve jacket |
US12090046B2 (en) | 2019-03-01 | 2024-09-17 | Edwards Lifesciences Corporation | Telescoping prosthetic valve with retention element |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
Also Published As
Publication number | Publication date |
---|---|
WO2000018333A1 (en) | 2000-04-06 |
US6334873B1 (en) | 2002-01-01 |
AU6259499A (en) | 2000-04-17 |
EP1117354A1 (en) | 2001-07-25 |
US20020026238A1 (en) | 2002-02-28 |
CN1328436A (en) | 2001-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002525169A (en) | Heart valve with tissue and outer sheath secured by anchor | |
US10238486B2 (en) | Heart valve with integrated stent and sewing ring | |
US10010413B2 (en) | Prosthetic heart valve including stent structure and tissue leaflets, and related methods | |
US6716244B2 (en) | Sewing cuff assembly for heart valves | |
US10058425B2 (en) | Methods of assembling a valved aortic conduit | |
US5861028A (en) | Natural tissue heart valve and stent prosthesis and method for making the same | |
JP4928036B2 (en) | Artificial heart valve with rotating cuff | |
AU739221B2 (en) | Natural tissue heart valves and methods of making same | |
CA2461531C (en) | Low-profile heart valve sewing ring | |
US11648116B2 (en) | Methods of assembling valved aortic conduits | |
JP2002519098A (en) | Single sutureable biological tissue aortic stentless valve | |
WO2000023006A1 (en) | Elastic valve with partially exposed stent | |
JPS61179147A (en) | Artificial heart valve | |
WO1997024989A1 (en) | Heart valve prosthesis and method for making same | |
EP0813398A1 (en) | Composite heart valve prosthesis and method for making same | |
WO2001012105A1 (en) | Autologous tissue suture ring used in heart valve implantation | |
AU774750B2 (en) | Natural tissue heart valves and methods of making same |